Skip to main content
PLOS Genetics logoLink to PLOS Genetics
. 2020 Mar 19;16(3):e1008638. doi: 10.1371/journal.pgen.1008638

Autophagy compensates for defects in mitochondrial dynamics

Simon Haeussler 1,#, Fabian Köhler 1,#, Michael Witting 2,3, Madeleine F Premm 1, Stéphane G Rolland 1, Christian Fischer 1,4, Laetitia Chauve 5, Olivia Casanueva 5, Barbara Conradt 1,4,6,*
Editor: Gregory P Copenhaver7
PMCID: PMC7135339  PMID: 32191694

Abstract

Compromising mitochondrial fusion or fission disrupts cellular homeostasis; however, the underlying mechanism(s) are not fully understood. The loss of C. elegans fzo-1MFN results in mitochondrial fragmentation, decreased mitochondrial membrane potential and the induction of the mitochondrial unfolded protein response (UPRmt). We performed a genome-wide RNAi screen for genes that when knocked-down suppress fzo-1MFN(lf)-induced UPRmt. Of the 299 genes identified, 143 encode negative regulators of autophagy, many of which have previously not been implicated in this cellular quality control mechanism. We present evidence that increased autophagic flux suppresses fzo-1MFN(lf)-induced UPRmt by increasing mitochondrial membrane potential rather than restoring mitochondrial morphology. Furthermore, we demonstrate that increased autophagic flux also suppresses UPRmt induction in response to a block in mitochondrial fission, but not in response to the loss of spg-7AFG3L2, which encodes a mitochondrial metalloprotease. Finally, we found that blocking mitochondrial fusion or fission leads to increased levels of certain types of triacylglycerols and that this is at least partially reverted by the induction of autophagy. We propose that the breakdown of these triacylglycerols through autophagy leads to elevated metabolic activity, thereby increasing mitochondrial membrane potential and restoring mitochondrial and cellular homeostasis.

Author summary

Various quality control mechanisms within the cell ensure mitochondrial homeostasis. Specifically, mitochondrial fission and fusion, the mitochondrial unfolded protein response (UPRmt) and/or mitophagy are induced upon mitochondrial stress to maintain or restore mitochondrial homeostasis. How these different quality control mechanisms are coordinated and how they influence each other is currently not well understood. Interestingly, the disruption of mitochondrial dynamics has recently been shown to induce UPRmt. We performed a genome-wide RNAi screen for suppressors of UPRmt induced by a block in mitochondrial fusion and found approximately half of the candidate genes identified to negatively regulate autophagy, a central quality control mechanism that adjusts cellular metabolism under conditions of stress. Furthermore, we found that induction of autophagy also suppresses UPRmt induced by a block in mitochondrial fission. In addition, we demonstrate that defects in mitochondrial dynamics lead to changes in lipid metabolism, which can partially be reverted by the induction of autophagy. Taken together, our results suggest a so far unknown functional connection between UPRmt and autophagy in animals with defects in mitochondrial dynamics.

Introduction

Mitochondrial dynamics plays an important role in the maintenance of mitochondrial function and, hence, cellular homeostasis [1]. Mitochondrial fission and fusion are both mediated by members of the family of dynamin-like guanosine triphosphatases (GTPases) [2]. In the nematode Caenorhabditis elegans, mitochondrial fission is facilitated by the cytosolic dynamin-like GTPase DRP-1DRP1, which is recruited to mitochondria where it presumably forms constricting spirals as shown for its Saccharomyces cerevisiae counterpart Drp1 [3,4]. Conversely, fusion of the outer and inner mitochondrial membranes is carried out by the membrane-anchored dynamin-like GTPases FZO-1MFN [5] and EAT-3OPA1 [6], respectively. The consequences with respect to mitochondrial function and cellular homeostasis of disrupting mitochondrial dynamics are not yet fully understood; however, it has recently been demonstrated that this activates a retrograde quality control signaling pathway referred to as the ‘mitochondrial Unfolded Protein Response’ (UPRmt) [7,8]. In C. elegans, UPRmt is activated upon mitochondrial stress, which leads to a decrease in mitochondrial membrane potential and the subsequent import into the nucleus of the ‘Activating Transcription Factor associated with Stress 1’ (ATFS-1ATF4,5) [9,10]. ATFS-1ATF4,5 harbors both an N-terminal mitochondrial targeting sequence and a C-terminal nuclear localization sequence and is normally imported into mitochondria [11]. Upon mitochondrial stress, ATFS-1ATF4,5 is imported into the nucleus, where it cooperates with the proteins UBL-5UBL5 and DVE-1SATB1 to promote the transcription of genes that act to restore mitochondrial function and to adjust cellular metabolism [9,10,12,13]. Among these genes are the mitochondrial chaperone genes hsp-6mtHSP70 and hsp-60HSP60, the transcriptional upregulation of which is commonly used to monitor UPRmt activation [14].

Whereas UPRmt is a quality control pathway that is activated upon mitochondrial stress, macro-autophagy (from now on referred to as ‘autophagy’) is a more general cellular quality control mechanism. Through autophagy, cytosolic constituents, long-lived proteins or dysfunctional organelles are degraded and recycled [15,16]. Upon the induction of autophagy, a double-membrane structure called ‘phagophore’ forms, which enlarges and eventually engulfs the cargo to form an ‘autophagosome’. The autophagosome then fuses with a lysosome to form an ‘autolysosome’, in which the engulfed cargo is subsequently degraded by lysosomal hydrolases [1618]. A key regulator of autophagy in C. elegans is the kinase LET-363mTOR [19]. When cellular nutrients are abundant, LET-363mTOR represses the ‘induction complex’, which includes UNC-51ULK, a kinase that initiates autophagy [2026].

Another vesicular process that targets cargo for degradation to the lysosome is endocytosis. The ‘Endosomal Sorting Complex Required for Transport’ (ESCRT) plays a critical role in endocytosis [27,28]. The ESCRT is composed of five different subcomplexes (ESCRT-0, -I, -II, -III and the AAA-ATPase VPS4) and was originally identified because of its role in the formation of multivesicular bodies (MVBs), which enables ubiquitinated membrane proteins to be sorted into small intralumenal vesicles (ILVs) [29,30]. The ESCRT has since been shown to be required for a number of other cellular processes, such as cytokinesis and virus budding [27,31,32]. ESCRT activity has also been shown to affect autophagy. Studies in mammals and Drosophila melanogaster demonstrated that depleting ESCRT components results in a block in autophagy and that in these animals, the ESCRT is required for the fusion of endosomes with lysosomal compartments and also autophagosomes [3336]. Moreover, ESCRT components have recently been shown to be involved in the closure of autophagosomes in mammals and yeast [37,38]. However, in C. elegans, the depletion of ESCRT components results in the induction of autophagy, which suggests that in this species, ESCRT function antagonizes or suppresses autophagy [39,40].

Whereas a functional connection between the ESCRT and autophagy has been established in yeast, nematodes, flies and mammals [3340], functional connections between the ESCRT and UPRmt or between autophagy and UPRmt [40] have not been described or are poorly understood. In this study, we present evidence that in C. elegans, the ESCRT, autophagy and UPRmt functionally interact. Specifically, we found that the induction of autophagy suppresses UPRmt induced by a block in mitochondrial fusion or fission. Interestingly, lipid profiling revealed alterations in the lipidome of mutants defective in mitochondrial dynamics, and we present evidence that changes in the levels of certain types of triacylglycerols (TGs) in fzo-1MFN mutants can be reverted by the induction of autophagy. We propose that through the breakdown of these triacylglycerols, the induction of autophagy leads to elevated metabolic activity, thereby increasing mitochondrial membrane potential and restoring mitochondrial and, hence, cellular homeostasis.

Results

In C. elegans, knock-down by RNA-mediated interference (RNAi) of genes encoding dynamin-like GTPases required for mitochondrial fusion (fzo-1MFN, eat-3OPA1) or mitochondrial fission (drp-1DRP1) induces the ‘mitochondrial Unfolded Protein Response’ (UPRmt) [7,8]. Using a multi-copy transgene of the transcriptional reporter Phsp-6 mtHSP70gfp (zcIs13) [14], we tested strong loss-of-function (lf) mutations of fzo-1MFN and drp-1DRP1 (fzo-1(tm1133), drp-1(tm1108) (National BioResource Project)) and found that they induce UPRmt to different degrees (S1A and S1C Fig). As a positive control, we used animals carrying a lf mutation of the gene spg-7AFG3L2 (spg-7(ad2249)), which encodes a mitochondrial metalloprotease required for mitochondrial function [41]. The zcIs13 transgene shows very low baseline expression in wild-type animals and is widely used to monitor UPRmt in C. elegans [7,914,4244]. In the case of fzo-1(tm1133) animals, for example, its expression is induced more than 15-fold (S1C Fig). Furthermore, RNAi knock-down of spg-7AFG3L2 or genes encoding subunits of the electron transport chain (ETC), or treatments with drugs targeting the latter (e.g. antimycin) lead to strong induction of zcIs13 expression [14,43]. This makes the zcIs13 transgene suitable for high throughput, large-scale screens.

However, considering that fzo-1(tm1133) causes an increase in the amount of endogenous HSP-6mtHSP70 protein by only 1.44-fold (S1E Fig), the fold induction observed with the multi-copy zcIs13 transgene may not reflect the physiological response with respect to UPRmt induction by the loss of fzo-1MFN. Furthermore, the zcIs13 transgene exhibits large variability in expression between animals (inter-individual variability) (S1A Fig), which makes it difficult to obtain consistent results, especially when knocking-down genes using RNA-mediated interference (RNAi). For this reason, we generated a single-copy transgene, bcSi9 (integrated at a defined chromosomal location using MosSCI), of the transcriptional reporter Phsp-6 mtHSP70gfp. As shown in S1B Fig, the bcSi9 transgene shows low baseline expression and, in the case of spg-7(ad2249) and fzo-1(tm1133), an increase in expression of ~5-fold or ~4-fold, respectively (S1D Fig). Furthermore, compared to fzo-1(tm1133) animals carrying the multi-copy transgene zcIs13, fzo-1(tm1133) animals carrying the single-copy transgene bcSi9 exhibit less inter-individual variability (S1A and S1B Fig). Similarly, drp-1(tm1108) animals carrying bcSi9 show significantly less inter-individual variability compared to drp-1(tm1108) animals carrying the multi-copy transgene zcIs13 (S1A and S1B Fig). Importantly, for all genotypes tested, we found that compared to the fold-induction observed with the multi-copy transgene zcIs13, the fold-induction observed with the single-copy transgene bcSi9 correlated better with the fold-induction observed in the amount of endogenous HSP-6mtHSP70 protein (S1A–S1E Fig). Finally, to compare inter-individual variability of the expression of the two Phsp-6 mtHSP70gfp transgenes zcIs13 and bcSi9 as well as the endogenous hsp-6mtHSP70 locus in a quantitative manner, we performed single-worm RT-qPCR experiments in synchronized populations of 36 individual animals and compared inter-individual variability in expression of zcIs13, bcSi9 or the endogenous hsp-6mtHSP70 locus to those of loci with low (hsp-1HSPA1L), medium (ttr-45) or high (nlp-29) inter-individual variability in expression, respectively (S1F Fig). While the expression of the endogenous hsp-6mtHSP70 locus is not variable between individuals of a population, the expression of the multi-copy transgene zcIs13 is highly variable in both a wild-type and fzo-1(tm1133) background (S1F Fig). Furthermore, the single-copy transgene bcSi9 exhibits some inter-individual variability in expression, however, to a much lower degree than the transgene zcIs13. Therefore, based on these results, we decided to use the multi-copy transgene zcIs13 for a genome-wide RNAi screen for suppressors of fzo-1(tm1133)-induced UPRmt and the single-copy transgene bcSi9 for subsequent analyses of candidates identified (see below).

Depletion of ESCRT components suppresses fzo-1(tm1133)-induced UPRmt

To identify genes that affect the induction of UPRmt in response to a block in mitochondrial fusion, we performed a genome-wide RNAi screen using fzo-1(tm1133) animals carrying the multi-copy Phsp-6 mtHSP70gfp transgene zcIs13 (S1A Fig). To that end, we used an RNAi feeding library that covers approximately 87% of C. elegans protein coding genes [45] and analyzed animals of the F1 generation. Among the 299 suppressors identified, three genes, vps-4VPS4, vps-20CHMP6 and vps-37VPS37, encode components of the ‘Endosomal Sorting Complex Required for Transport’ (ESCRT) [2730]. We analyzed the suppression of fzo-1(tm1133)-induced UPRmt using the single-copy Phsp-6 mtHSP70gfp transgene bcSi9 and found that knock-down of vps-4VPS4 or vps-20CHMP6 by RNAi (referred to as ‘vps-4(RNAi)’ or ‘vps-20(RNAi)’) causes suppression by 39% or 23% on average, respectively (Fig 1A and 1C). vps-37(RNAi) does not result in a statistically significant suppression on average; however, some individual animals show strong suppression (see Fig 1A; vps-37(RNAi); red arrowheads). As a positive control, we knocked-down the function of atfs-1ATF4,5 by RNAi, which results in suppression of fzo-1(tm1133)-induced UPRmt by 54% on average. (In a wild-type background, atfs-1(RNAi), vps-4(RNAi) or vps-20(RNAi) suppresses baseline expression of the bcSi9 transgene by 8%, 14% or 14%, respectively (S2A Fig).) To confirm the suppression of fzo-1(tm1133)-induced UPRmt upon ESCRT(RNAi), we used a multi-copy transgene (zcIs9) of a transcriptional reporter of the gene hsp-60HSP60 (Phsp-60 HSP60gfp), which is also transcriptionally upregulated in response to the induction of UPRmt [14]. Using the Phsp-60 HSP60gfp reporter, we found that vps-37(RNAi), vps-20(RNAi) or vps-4(RNAi) suppresses by 34%, 41% or 33% on average, respectively (Fig 1B and 1D).

Fig 1. Depletion of ESCRT components and LET-363 suppresses fzo-1(tm1133)-induced UPRmt.

Fig 1

(A) Fluorescence images of L4 larvae expressing Phsp-6gfp (bcSi9) in wild type (+/+) or fzo-1(tm1133). L4 larvae were subjected to control(RNAi), atfs-1(RNAi), vps-4(RNAi), vps-20(RNAi), vps-22(RNAi), hgrs-1(RNAi), vps-36(RNAi), vps-37(RNAi) or let-363(RNAi) and the F1 generation was imaged. Red arrowheads indicate suppressed animals upon vps-37(RNAi). Scale bar: 200 μm. (B) Fluorescence images of L4 larvae expressing Phsp-60gfp (zcIs9) in wild type (+/+) or fzo-1(tm1133). L4 larvae were subjected to control(RNAi), atfs-1(RNAi), vps-4(RNAi), vps-20(RNAi), vps-22(RNAi), hgrs-1(RNAi), vps-36(RNAi), vps-37(RNAi) or let-363(RNAi) and the F1 generation was imaged. Scale bar: 200 μm. (C) Quantifications of fluorescence images from panel A. After subtracting the mean fluorescence intensity of wild type (+/+) on control(RNAi), the values were normalized to fzo-1(tm1133) on control(RNAi). Each dot represents the quantification of fluorescence intensity of 15–20 L4 larvae. Values indicate means ± SD of at least 3 independent experiments in duplicates. **P<0.01, ****P<0.0001 using one-way ANOVA with Dunnett’s multiple comparison test to control(RNAi). (D) Quantifications of fluorescence images from panel B. After subtracting the mean fluorescence intensity of wild type (+/+) on control(RNAi), the values were normalized to fzo-1(tm1133) on control(RNAi). Each dot represents the quantification of fluorescence intensity of 10–20 L4 larvae. Values indicate means ± SD of 3 independent experiments in duplicates. ns: not significant, *P<0.05, **P<0.01, ****P<0.0001 using Kruskal-Wallis test with Dunn’s multiple comparison test to control(RNAi).

To validate that the reduced Phsp-6 mtHSP70gfp (bcSi9) and Phsp-60 HSP60gfp (zcIs9) expression in fzo-1(tm1133) animals upon ESCRT(RNAi) is specific to the UPRmt response, we tested a transcriptional reporter, Pges-1 CES2gfp, that has a similar expression pattern as the two UPRmt reporters. Depletion of ESCRT component VPS-4VPS4 or VPS-20CHMP6 does not result in suppression of the Pges-1 CES2gfp reporter (Fig 2A and 2B), suggesting that ESCRT depletion does not cause degradation of cytosolic GFP per se but specifically suppresses the expression of the two UPRmt reporters.

Fig 2. Induction of autophagy increases mitochondrial membrane potential and suppresses fzo-1(tm1133)-induced UPRmt.

Fig 2

(A) Fluorescence images of L4 larvae expressing Pges-1gfp in wild type (+/+). L4 larvae were subjected to control(RNAi), vps-4(RNAi), vps-20(RNAi), let-363(RNAi) or hars-1(RNAi) and the F1 generation was imaged. Scale bar: 200 μm. (B) Quantifications of fluorescence images from panel A. The values were normalized to control(RNAi) and each dot represents the quantification of fluorescence intensity of 15–20 L4 larvae. Values indicate means ± SD of 3 independent experiments in duplicates. ns: not significant, ****P<0.0001 using one-way ANOVA with Dunnett’s multiple comparison test to control(RNAi). (C) Fluorescence images of L4 larvae expressing Pmyo-3gfpmt in wild type (+/+) or fzo-1(tm1133). L4 larvae were subjected to control(RNAi), atfs-1(RNAi), vps-4(RNAi), vps-20(RNAi), vps-37(RNAi) or let-363(RNAi) and the F1 generation was imaged. Scale bar: 10 μm. (D) Fluorescence images and quantifications of L4 larvae stained with TMRE in wild type (+/+) or fzo-1(tm1133). L4 larvae were subjected to control(RNAi) and the F1 generation was stained with TMRE overnight and imaged. Scale bar: 10 μm. Values indicate means ± SD of 3 independent experiments in duplicates. ****P<0.0001 using unpaired two-tailed t-test with Welch’s correction. (E) Fluorescence images of L4 larvae stained with TMRE in fzo-1(tm1133). L4 larvae were subjected to control(RNAi), vps-4(RNAi), vps-20(RNAi), let-363(RNAi) or hars-1(RNAi) and the F1 generation was stained with TMRE overnight and imaged. Scale bar: 10 μm. (F) Quantifications of fluorescence images from panel E. The values were normalized to fzo-1(tm1133) on control(RNAi) and each dot represents the quantification of fluorescence intensity per area from one L4 larvae. Values indicate means ± SD of 3 independent experiments in duplicates. ns: not significant, *P<0.05, **P<0.01, ***P<0.001 using Kruskal-Wallis test with Dunn’s multiple comparison test to control(RNAi). (G) Fluorescence images of wild-type L4 larvae stained with TMRE. L4 larvae were subjected to control(RNAi), vps-4(RNAi), vps-20(RNAi), let-363(RNAi) or hars-1(RNAi) and the F1 generation was stained with TMRE overnight and imaged. Scale bar: 10 μm. (H) Quantifications of fluorescence images from panel G. The values were normalized to wild type on control(RNAi) and each dot represents the quantification of fluorescence intensity per area from one L4 larvae. Values indicate means ± SD of 3 independent experiments in duplicates. **P<0.01, ****P<0.0001 using Kruskal-Wallis test with Dunn’s multiple comparison test to control(RNAi).

Since vps-4VPS4, vps-20CHMP6 and vps-37VPS37 are part of different ESCRT subcomplexes (vps-4VPS4ATPase, vps-20CHMP6ESCRT-III, vps-37VPS37ESCRT-I) [27], we tested whether depletion of components of the two remaining ESCRT subcomplexes, ESCRT-0 and ESCRT-II, also suppresses fzo-1(tm1133)-induced UPRmt. Using the Phsp-6 mtHSP70gfp reporter (bcSi9), we found that RNAi knock-down of hgrs-1HGS (ESCRT-0) suppresses by 23% on average (Fig 1A and 1C). In contrast, RNAi knock-down of two genes encoding components of ESCRT-II, vps-22SNF8 and vps-36VPS36, fails to suppress. Similarly, using the Phsp-60 HSP60gfp reporter (zcIs9), we found suppression by hgrs-1(RNAi) but not vps-22(RNAi) or vps-36(RNAi) (Fig 1B and 1D). Taken together, our results demonstrate that the depletion of components of ESCRT-0, -I, -III or VPS-4 ATPase can suppress fzo-1(tm1133)-induced UPRmt.

Depletion of ESCRT components does not rescue the fragmented mitochondria phenotype in fzo-1(tm1133) animals but increases mitochondrial membrane potential

The loss of fzo-1MFN function has a dramatic effect on steady-state mitochondrial morphology. This is easily detectable in C. elegans body wall muscles using a reporter that drives the expression of mitochondrial-matrix targeted GFP protein (Pmyo-3 MYHgfpmt) [3,5,46]. In control(RNAi) animals, the mitochondria in body wall muscle cells are predominantly tubular (Fig 2C). In contrast, in fzo-1(tm1133) animals treated with control(RNAi), the mitochondria are predominantly fragmented (referred to as ‘fragmented mitochondria’ phenotype). To determine whether the depletion of components of ESCRT-I or -III, or the depletion of the ATPase VPS-4VPS4 restores steady-state mitochondrial morphology, we analyzed mitochondrial morphology in fzo-1(tm1133) animals, in which vps-4VPS4, vps-20CHMP6 or vps-37VPS37 had been knocked-down by RNAi. We found that knock-down of these genes has no effect on the fragmented mitochondria phenotype in body wall muscle cells of fzo-1(tm1133) animals (Fig 2C). Knock-down of vps-4VPS4, vps-20CHMP6 or vps-37VPS37 in fzo-1(tm1133) animals also has no effect on mitochondrial morphology in hypodermal or intestinal cells (Fig 2E and S3B Fig). (ESCRT depletion has no effect on steady-state mitochondrial morphology in body wall muscle cells in a wild-type background (S3A Fig).)

Since we did not see a change in mitochondrial morphology in fzo-1(tm1133) animals upon ESCRT(RNAi), we tested whether it affects mitochondrial membrane potential. Therefore, we stained larvae with TMRE (Tetramethylrhodamine ethyl ester), a membrane potential dependent dye that is commonly used in C. elegans to measure mitochondrial membrane potential in hypodermal cells [10,14]. To measure the intensity of TMRE signal, mitochondria in the fluorescent images were segmented using Fiji image software to generate a binary mask (S4 Fig). This mask, which includes all mitochondria of an image, was then used to measure TMRE fluorescence intensity per mitochondrial area in the raw image. Compared to wild type, TMRE fluorescence intensity per mitochondrial area was reduced by 63% in fzo-1(tm1133) animals (Fig 2D). We found increased levels of TMRE fluorescence intensity per mitochondrial area in fzo-1(tm1133) animals upon vps-4(RNAi) (19%) or vps-20(RNAi) (33%), compared to control(RNAi) (Fig 2E and 2F). In contrast, ESCRT depletion in the wild-type background causes a reduction in TMRE fluorescence intensity per mitochondrial area by 24% upon vps-4(RNAi) or 18% upon vps-20(RNAi) (Fig 2G and 2H). Mitochondrial TMRE fluorescence intensity is proportional to mitochondrial membrane potential [47]. Therefore, ESCRT(RNAi) results in an increase in mitochondrial membrane potential in fzo-1(tm1133) mutants. Hence, our data suggests that the suppression of fzo-1(tm1133)-induced UPRmt upon ESCRT depletion is due to rescue of the decreased mitochondrial membrane potential and not the fragmented mitochondria phenotype.

Depletion of ESCRT components increases autophagic flux in fzo-1(tm1133) animals

Previous studies have shown that in C. elegans, the depletion of ESCRT components leads to the induction of autophagy [39,40]. We confirmed this in wild-type animals (S2B Fig) and tested whether ESCRT depletion also induces autophagy in fzo-1(tm1133) animals. First, we determined the basal level of autophagy in fzo-1(tm1133) animals using three different assays that utilize the reporters Plgg-1 GABARAPgfp::lgg-1 and Psqst-1 p62sqst-1::gfp, which are widely used to monitor autophagy in C. elegans [40,4852]. Specifically, we determined the number of GFP::LGG-1GABARAP foci in hypodermal seam cells of animals of the fourth larval stage (L4 larvae) and found that the average number of GFP::LGG-1GABARAP foci increases from ~4 on average in wild-type animals (+/+) to ~23 on average in fzo-1(tm1133) animals (Fig 3A and 3B). As a positive control, we used RNAi against the gene let-363mTOR, which induces autophagy when knocked-down [19]. As expected, let-363(RNAi) animals show an increase in the number of GFP::LGG-1GABARAP foci in hypodermal seam cells (~15 on average) (Fig 3A and 3B). To determine whether the increase in the number of GFP::LGG-1GABARAP foci is caused by a block in autophagy, we analyzed the expression of the reporter Psqst-1 p62sqst-1::gfp. (The accumulation of SQST-1p62::GFP is indicative of defective autophagic clearance [51].) Whereas embryos homozygous for a lf mutation of unc-51ULK, e369, a gene required for autophagy [26], show strong accumulation of SQST-1p62::GFP, we found that fzo-1(tm1133) embryos do not accumulate SQST-1p62::GFP (Fig 3C). To further verify an increase in autophagic flux in fzo-1(tm1133) animals, we used an immunoblotting assay based on the cleavage of the GFP::LGG-1GABARAP fusion protein (in autolysosomes) to generate a ‘free GFP’ fragment, referred to as ‘cleaved GFP’ [50,53,54]. As shown in Fig 3D, compared to wild type, fzo-1(tm1133) mutants exhibit a ~2.7-fold increase on average in the level of cleaved GFP. This confirms that autophagic flux is increased in animals lacking fzo-1MFN.

Fig 3. Autophagy is induced independently of ATFS-1ATF4,5 in fzo-1(tm1133) animals and further increased after ESCRT depletion.

Fig 3

(A) Plgg-1gfp::lgg-1 expression in hypodermal seam cells of wild type (+/+), fzo-1(tm1133) or fzo-1(tm1133); atfs-1(tm4525) L4 larvae. For RNAi against let-363 and atfs-1, L4 larvae were subjected to the respective RNAi and the F1 generation was imaged. Scale bar: 5 μm. (B) Quantification of GFP::LGG-1 foci in hypodermal seam cells from panel A. Each dot represents the average amount of GFP::LGG-1 foci counted from 2–5 seam cells in one animal. n≥12 for each genotype; values indicate means ± SD; ns: not significant, ***P<0.001, ****P<0.0001 using Kruskal-Wallis test with Dunn’s multiple comparison to wild type (+/+) or fzo-1(tm1133), respectively. (C) Nomarski and fluorescent images of the Psqst-1sqst-1::gfp translational reporter in embryos of wild type (+/+) or fzo-1(tm1133). As a positive control for a block in autophagy, unc-51(e369) was used. Representative images of >60 embryos are shown. Scale bar: 10 μm. (D) Western blot analysis of cleaved GFP levels in wild type (+/+) or fzo-1(tm1133) using anti-GFP antibodies. Quantification of three independent experiments is shown. Values indicate means ± SD. (E) Plgg-1gfp::lgg-1 expression of fzo-1(tm1133) L4 larvae in hypodermal seam cells and intestinal cells upon control(RNAi), vps-4(RNAi), vps-20(RNAi), vps-22(RNAi), hgrs-1(RNAi), vps-36(RNAi) or vps-37(RNAi). Representative images of >80 animals from four independent biological replicates are shown. Scale bar hypodermal seam cells: 5 μm. Scale bar intestinal cells: 20 μm. (F) Western blot analysis of cleaved GFP levels in fzo-1(tm1133) upon control(RNAi), vps-4(RNAi) or vps-20(RNAi) using anti-GFP antibodies. Quantification of four independent experiments is shown. Values indicate means ± SD.

To test whether depletion of ESCRT components can further increase autophagy in fzo-1(tm1133) animals, we knocked-down vps-4VPS4, vps-20CHMP6, hgrs-1HGS or vps-37VPS37 in fzo-1(tm1133) animals and analyzed GFP::LGG-1GABARAP foci using the Plgg-1 GABARAPgfp::lgg-1 reporter. We found that RNAi knock-down of each of these four genes in fzo-1(tm1133) animals causes a dramatic increase in the accumulation of GFP::LGG-1GABARAP foci in hypodermal seam cells as well as intestinal cells (Fig 3E). Furthermore, compared to control(RNAi)-treated animals, we found increased levels of cleaved GFP in fzo-1(tm1133) animals treated with vps-4(RNAi) (~5.5-fold) or vps-20(RNAi) (~5.9-fold) (Fig 3F). However, RNAi against the ESCRT-II components vps-22SNF8 or vps-36VPS36 (which fail to suppress fzo-1(tm1133)-induced UPRmt when knocked-down (Fig 1A–1D)) has no effect on the formation of GFP::LGG-1GABARAP foci in hypodermal seam cells or intestinal cells (Fig 3E), probably due to an inefficient knock-down. In summary, our findings demonstrate that the depletion of components of ESCRT-0, -I, -III or the VPS-4 ATPase increases autophagic flux in fzo-1(tm1133) animals.

Induction of autophagy suppresses fzo-1(tm1133)-induced UPRmt

To determine whether increasing autophagy through means other than knock-down of ESCRT components also suppresses fzo-1(tm1133)-induced UPRmt, we knocked-down let-363mTOR by RNAi and examined the expression of Phsp-6 mtHSP70gfp (bcSi9) and Phsp-60 HSP60gfp (zcIs9) in fzo-1(tm1133) animals. We found that compared to controls, the expression of both reporters is significantly suppressed upon let-363(RNAi) in fzo-1(tm1133) animals (Fig 1A–1D). Specifically, on average, the expression of Phsp-6 mtHSP70gfp is suppressed by 40% and that of Phsp-60 HSP60gfp by 45%, which is comparable to the level of suppression observed upon RNAi knock-down of either atfs-1ATF4,5 or vps-4VPS4. As shown for the depletion of ESCRT components, mitochondrial morphology upon let-363(RNAi) was found not to be altered in fzo-1(tm1133) or wild-type animals (Fig 2C, 2E and 2G and S3A and S3B Fig).

To obtain further evidence that induction of autophagy leads to suppression of fzo-1(tm1133)-induced UPRmt, we searched for additional genes with a regulatory role in autophagy in our dataset of 299 suppressors. We found 17 additional genes that were previously identified in a genome-wide RNAi screen for regulators of autophagy in C. elegans [40] (Fig 4A). Moreover, we used a database of autophagy-related genes and their orthologs (http://www.tanpaku.org/autophagy/index.html) [55], results from two screens for regulators of autophagy in mammals [56,57], three interaction databases (wormbase.org, genemania.org and string-db.org) followed by literature searches and identified 13 additional genes in our dataset that potentially induce autophagy upon knock-down (Fig 4A) [5874]. Therefore, including the three genes encoding components of the ESCRT (vps-4VPS4, vps-20CHMP6, vps-37VPS37), 33 of the 299 suppressors have previously been shown to induce autophagy when knocked-down.

Fig 4. Additional candidates identified by RNAi screen that suppress fzo-1(tm1133)- and drp-1(tm1108)-induced UPRmt through activation of autophagy.

Fig 4

(A) List of candidate genes identified in the primary screen with fzo-1(tm1133); Phsp-6gfp (zcIs13) by RNAi. L4 larvae were subjected to the respective RNAi and the F1 generation was imaged. Candidate genes were screened three times in technical duplicates with the same reporter in two different mutant backgrounds: drp-1(tm1108) and spg-7(ad2249). Fluorescence intensity was scored and classified from very strong suppression to weak suppression (gradual violet coloring) or no suppression (white). § indicates genes that, upon knock-down in our experiments, showed accumulation of GFP::LGG-1 dots in hypodermal seam cells or intestinal cells. (B) Plgg-1gfp::lgg-1 expression of fzo-1(tm1133) L4 larvae in intestinal cells upon control(RNAi), cogc-2(RNAi), cogc-4(RNAi), hars-1(RNAi), ins-7(RNAi), rpt-3(RNAi) or smgl-1(RNAi). Representative images of >60 animals from four independent biological replicates are shown. Scale bar: 20 μm. (C) Western blot analysis of cleaved GFP levels in fzo-1(tm1133) upon control(RNAi), smgl-1(RNAi), ins-7(RNAi), hars-1(RNAi), cogc-2(RNAi), cogc-4(RNAi) or rpt-3(RNAi) using anti-GFP antibodies. Quantification of three independent experiments is shown. Values indicate means ± SD. (D) Fluorescence images of L4 larvae expressing Phsp-6gfp (bcSi9) in wild type (+/+) or fzo-1(tm1133). L4 larvae were subjected to control(RNAi), atfs-1(RNAi), cogc-2(RNAi), cogc-4(RNAi), hars-1(RNAi), ins-7(RNAi), rpt-3(RNAi) or smgl-1(RNAi) and the F1 generation was imaged. Scale bar: 200 μm. (E) Quantifications of fluorescence images from panel D. After subtracting the mean fluorescence intensity of wild type (+/+) on control(RNAi), the values were normalized to fzo-1(tm1133) on control(RNAi). Each dot represents the quantification of fluorescence intensity of 15–20 L4 larvae. Values indicate means ± SD of at least 3 independent experiments in duplicates. ns: not significant, *P<0.05, ***P<0.001, ****P<0.0001 using one-way ANOVA with Dunnett’s multiple comparison test to control(RNAi).

Finally, we knocked-down all 299 suppressors in an otherwise wild-type background and tested for an increase in autophagy. Using this approach, we found that 126 genes encode negative regulators of autophagy (16 of which were among the 33 genes identified through our literature search; indicated by § in Fig 4A), since they result in the accumulation of GFP::LGG-1GABARAP foci in hypodermal seam cells and/or intestinal cells of larvae but not in the accumulation of SQST-1p62::GFP in embryos when knocked-down (S1 Table). Adding the 17 genes that we identified through literature searches, which were not found in this ‘autophagy’ screen (Fig 4A), we, in total, found 143 out of 299 suppressors (~48%) of fzo-1(tm1133)-induced UPRmt to negatively regulate autophagy.

To confirm that the additionally identified genes enhance autophagy also in the fzo-1(tm1133) background, we knocked-down six of them (cogc-2COG2, cogc-4COG4, hars-1HARS, rpt-3PSMC4, smgl-1NBAS and ins-7) and tested them for increased autophagic flux in fzo-1(tm1133) animals. We found that the knock-down of each gene causes an increase in autophagic flux in fzo-1(tm1133) animals, most prominently in the intestine (Fig 4B). We also determined the level of cleaved GFP in these animals and found that, compared to fzo-1(tm1133) animals on control(RNAi), the level is increased ranging from ~1.5-fold upon rpt-3(RNAi) to ~7.4-fold upon hars-1(RNAi) (Fig 4C). Using the single-copy Phsp-6 mtHSP70gfp transgene bcSi9, we confirmed that the knock-down of cogc-2COG2, cogc-4COG4, hars-1HARS, rpt-3PSMC4, smgl-1NBAS or ins-7 suppresses fzo-1(tm1133)-induced UPRmt (Fig 4D and 4E). Therefore, we propose that it is the increase in autophagic flux that suppresses fzo-1(tm1133)-induced UPRmt.

Since let-363mTOR as well as some of the additionally identified candidates (such as hars-1HARS, rars-1RARS, tars-1TARS or iars-1IARS) have roles in translation [19], we tested the effects of the depletion of let-363mTOR or hars-1HARS on Pges-1 GES2gfp expression in order to exclude that their depletion simply attenuates synthesis of GFP protein. We found that let-363(RNAi) or hars-1(RNAi) leads to suppression of Pges-1 GES2gfp expression by 39% or 25%, respectively (Fig 2A and 2B). However, we found that depletion of let-363mTOR or hars-1HARS also has a beneficial effect on mitochondrial membrane potential in fzo-1(tm1133) mutants since TMRE fluorescence intensity per mitochondrial area is increased by 14% or 31%, respectively while having the opposite effect in wild-type animals, in which it is decreased by 40% or 47%, respectively (Fig 2E–2H). This suggests that the suppression of fzo-1(tm1133)-induced UPRmt upon depletion of let-363mTOR or hars-1HARS is the result of a combination of an increase in mitochondrial membrane potential and the attenuation of cytosolic translation.

The induction of autophagy is not per se beneficial for organismal fitness

Since mitochondrial membrane potential is increased in fzo-1(tm1133) animals upon induction of autophagy, we tested whether this has a beneficial effect at the organismal level. Using the ‘thrashing’ assay [75,76], we tested whether the motility of fzo-1(tm1133) animals is improved. As previously shown [77], thrashing rates are decreased in fzo-1(tm1133) mutants when compared to wild type (S5A Fig). We found that thrashing rates do not change upon vps-4(RNAi) or vps-20(RNAi) in either fzo-1(tm1133) or wild-type animals (S5B and S5C Fig). Therefore, increasing autophagic flux does not per se have beneficial effects on organismal fitness. In contrast, we found that thrashing rates are significantly increased upon let-363(RNAi) or hars-1(RNAi) in both fzo-1(tm1133) and wild-type animals (S5B and S5C Fig). Thus, the induction of autophagy can lead to increased motility under certain circumstances, but this effect may be covered upon depletion of ESCRT.

Depletion of ESCRT components in fzo-1(tm1133) animals with a block in autophagy results in embryonic lethality

To test the hypothesis that increased autophagic flux is necessary for the suppression of fzo-1(tm1133)-induced UPRmt in ESCRT-depleted animals, we generated a fzo-1(tm1133); unc-51(e369) double mutant in the Phsp-6 mtHSP70gfp (bcSi9) reporter background and subjected it to RNAi against either vps-4VPS4 or vps-20CHMP6. However, we found that either RNAi treatment results in progeny that undergoes embryonic arrest. To circumvent this problem, we subjected fzo-1(tm1133) mutants to double-RNAi against unc-51ULK and ESCRT but failed to detect suppression of UPRmt upon ESCRT(RNAi) diluted with control(RNAi) (S6A Fig). Next, we depleted ESCRT components by RNAi starting from the second larval stage (L2) (rather than in the parental generation and throughout development) and examined reporter expression once the animals had reached the fourth larval stage (L4). Interestingly, we found that subjecting fzo-1(tm1133) L2 larvae to vps-4(RNAi) or vps-20(RNAi) does not increase autophagic flux and fails to suppress UPRmt, while atfs-1(RNAi) is able to suppress UPRmt under these conditions (S6B and S6C Fig). We repeated this experiment in the background of an RNAi-sensitizing mutation, rrf-3(pk1426), but again were unable to detect suppression of the Phsp-6 mtHSP70gfp (bcSi9) reporter upon ESCRT(RNAi) while atfs-1(RNAi) suppressed (S6D Fig). Based on these results, we conclude that ESCRT(RNAi) does not directly act on ATFS-1ATF4,5 to suppress UPRmt. Instead, we propose that it affects UPRmt indirectly through the induction of autophagy.

Blocking mitophagy does not prevent suppression in fzo-1(tm1133) animals of UPRmt by ESCRT depletion

Since we were unable to test whether blocking autophagy blocks the suppression of fzo-1(tm1133)-induced UPRmt by depletion of ESCRT components, we tested the role of pdr-1Parkin- and fndc-1FUNDC1,2-dependent mitophagy in this context [78,79]. First, we used fzo-1(tm1133); pdr-1(lg103) double mutants, carrying the Phsp-6 mtHSP70gfp (bcSi9) reporter, to test whether pdr-1Parkin-dependent mitophagy is required for ESCRT-dependent suppression of fzo-1(tm1133)-induced UPRmt. We found that knock-down of vps-4VPS4, vps-20CHMP6 or hgrs-1HGS still suppresses fzo-1(tm1133)-induced UPRmt in the pdr-1(lg103) background (Fig 5A and 5B). Furthermore, compared to the level of suppression in fzo-1(tm1133) animals alone, the level of UPRmt suppression in fzo-1(tm1133); pdr-1(lg103) animals is similar upon vps-4(RNAi) or vps-20(RNAi) and even higher upon hgrs-1(RNAi) (Figs 1A, 1C, 5A and 5B). Second, we tested whether depletion of ESCRT components suppresses UPRmt in fzo-1(tm1133) fndc-1(rny14) double mutants and found that it does so to a similar extent (Fig 5C and 5D). Therefore, pdr-1Parkin- and fndc-1FUNDC1,2-dependent mitophagy are not required for the suppression of fzo-1(tm1133)-induced UPRmt upon ESCRT depletion.

Fig 5. Functional interactions between mitophagy, autophagy and UPRmt.

Fig 5

(A) L4 larvae of fzo-1(tm1133); pdr-1(lg103) expressing Phsp-6gfp (bcSi9) were subjected to control(RNAi), atfs-1(RNAi), vps-4(RNAi), vps-20(RNAi) or hgrs-1(RNAi) and the F1 generation was imaged. Scale bar: 200 μm. (B) Quantifications of fluorescence images from panel A. After subtracting the mean fluorescence intensity of wild type (+/+) on control(RNAi), the values were normalized to fzo-1(tm1133); pdr-1(lg103) on control(RNAi). Each dot represents the quantification of fluorescence intensity of 15–20 L4 larvae. Values indicate means ± SD of 3 independent experiments in duplicates. **P<0.01, ***P<0.001, ****P<0.0001 using one-way ANOVA with Dunnett’s multiple comparison test to control(RNAi). (C) L4 larvae of fzo-1(tm1133) fndc-1(rny14) expressing Phsp-6gfp (bcSi9) were subjected to control(RNAi), atfs-1(RNAi), vps-4(RNAi) or vps-20(RNAi) and the F1 generation was imaged. Scale bar: 200 μm. (D) Quantifications of fluorescence images from panel C. After subtracting the mean fluorescence intensity of wild type (+/+) on control(RNAi), the values were normalized to fzo-1(tm1133) fndc-1(rny-14) on control(RNAi). Each dot represents the quantification of fluorescence intensity of 15–20 L4 larvae. Values indicate means ± SD of 3 independent experiments in duplicates. ***P<0.001, ****P<0.0001 using one-way ANOVA with Dunnett’s multiple comparison test to control(RNAi). (E) Fluorescence images of L4 larvae expressing Phsp-6gfp (bcSi9) in wild type (+/+), unc-51(e369), fzo-1(tm1133) or fzo-1(tm1133); unc-51(e369). Scale bar: 200 μm. (F) Quantifications of fluorescence images from panel E. Each dot represents the quantification of fluorescence intensity of 15–20 L4 larvae. Values indicate means ± SD of at least 4 independent experiments in duplicates. ns: not significant, ****P<0.0001 using two-tailed t-test. (G) Plgg-1gfp::lgg-1 expression in hypodermal seam cells of wild type (+/+), atfs-1(tm4525) or atfs-1(et15gf) L4 larvae. Scale bar: 5 μm. (H) Quantification of GFP::LGG-1 foci in hypodermal seam cells from panel G. Each dot represents the average amount of GFP::LGG-1 foci counted from 2–5 seam cells in one animal. n≥12 for each genotype; values indicate means ± SD; ns: not significant using one-way ANOVA with Dunnett’s multiple comparison test to wild type (+/+). (I) Nomarski and fluorescent images of the Psqst-1sqst-1::gfp translational reporter in embryos of wild type (+/+), atfs-1(tm4525) or atfs-1(et15gf) animals. As a positive control for a block in autophagy, unc-51(e369) was used. Representative images of >60 embryos are shown. Scale bar: 10 μm.

Blocking autophagy in the absence of mitochondrial stress induces UPRmt, but neither blocking nor inducing UPRmt affects autophagy

Increasing autophagic flux suppresses fzo-1(tm1133)-induced UPRmt. To test whether decreasing autophagic flux, conversely, induces UPRmt, we analyzed unc-51(e369) animals (in which autophagy is blocked) and found that compared to wild-type animals, the Phsp-6 mtHSP70gfp reporter is induced by 41% on average (Fig 5E and 5F). To determine whether the Phsp-6 mtHSP70gfp reporter is also induced under conditions where UPRmt is already activated, we analyzed fzo-1(tm1133); unc-51(e369) double mutant animals. We found that, in the fzo-1(tm1133) background, the loss of unc-51ULK does not result in a significant increase in the expression of Phsp-6 mtHSP70gfp (Fig 5E and 5F). Thus, blocking autophagy induces UPRmt in the absence of mitochondrial stress but not under conditions where UPRmt is already activated.

Next, we analyzed whether blocking or inducing UPRmt affects autophagy. Therefore, we analyzed autophagy in animals homozygous for either the atfs-1ATF4,5 lf mutation tm4525 or the atfs-1ATF4,5 gain-of-function (gf) mutation et15gf [11,80]. atfs-1(tm4525) has been shown to suppress the expression of the Phsp-6 mtHSP70gfp and Phsp-60 HSP60gfp reporters upon spg-7(RNAi) and of the endogenous hsp-6mtHSP70 and hsp-60HSP60 loci upon cco-1(RNAi) [11,81]. Conversely, atfs-1(et15gf) has been shown to constitutively activate UPRmt [80]. We found that compared to wild-type animals, hypodermal seam cells of atfs-1(tm4525) or atfs-1(et15gf) animals show no significant changes in the number of GFP::LGG-1GABARAP foci (Fig 5G and 5H). In addition, atfs-1(tm4525) or atfs-1(et15gf) embryos do not accumulate SQST-1p62::GFP foci (Fig 5I). Since it has previously been reported that mitochondrial stress induces autophagy in an atfs-1ATF4,5-dependent manner [40], we also tested whether the loss of atfs-1ATF4,5 suppresses autophagy in fzo-1(tm1133) animals. We found that the number of GFP::LGG-1GABARAP foci remains unchanged both in fzo-1(tm1133) animals upon atfs-1(RNAi) as well as fzo-1(tm1133); atfs-1(tm4525) double mutants (Fig 3A and 3B), demonstrating that the induction of autophagy in fzo-1(tm1133) mutants is ATFS-1ATF4,5-independent. Finally, we tested whether increasing UPRmt in fzo-1(tm1133) mutants by introducing atfs-1(et15gf) affects autophagic flux. However, we found that fzo-1(tm1133); atfs-1(et15gf) double mutants are not viable. Therefore, blocking or inducing UPRmt by manipulating ATFS-1ATF4,5 activity does not affect autophagic flux in wild type and blocking UPRmt does not affect autophagy in fzo-1(tm1133) animals.

The induction of autophagy suppresses UPRmt induced by a block in mitochondrial dynamics but not by the loss of spg-7AFG3L2

To determine whether the suppression of UPRmt by increased autophagic flux is specific to fzo-1(tm1133)-induced UPRmt, we tested all 143 suppressors of fzo-1(tm1133)-induced UPRmt with a role in autophagy for their ability to suppress drp-1(tm1108)- or spg-7(ad2249)-induced UPRmt using the multi-copy Phsp-6 mtHSP70gfp transgene zcIs13. As shown in Fig 4A and S1 Table, we found that the knock-down of 138 of the genes (~97%) also suppresses drp-1(tm1108)-induced UPRmt. In contrast, the knock-down of 90 of the genes (~63%) suppresses spg-7(ad2249)-induced UPRmt. Among these 90 genes, 41 belong to the GO categories ‘Translation’ or ‘Ribosome Biogenesis’. Hence, their depletion may interfere with synthesis of GFP.

Interestingly, we found that knock-down of vps-4VPS4 but not vps-20CHMP6 or vps-37VPS37 also suppresses spg-7(ad2249)-induced UPRmt (Fig 4A). Therefore, we tested whether the knock-down of vps-4VPS4 or vps-20CHMP6 leads to increased autophagic flux in spg-7(ad2249) animals. We first analyzed the basal level of autophagy in spg-7(ad2249) animals using the Plgg-1 GABARAPgfp::lgg-1 reporter and found that compared to wild type, the number of GFP::LGG-1GABARAP foci is increased 2-fold (from ~4 on average in wild-type animals to ~8 on average in spg-7(ad2249) animals) (S7A and S7B Fig). To determine whether this increase in autophagosomes is due to a block in autophagy, we analyzed the accumulation of SQST-1p62::GFP using the Psqst-1 p62sqst-1::gfp reporter. We did not observe SQST-1p62::GFP accumulation in spg-7(ad2249) animals, thus indicating that autophagic flux is increased in spg-7(ad2249) mutants (S7C Fig). Next, we tested whether vps-4(RNAi) or vps-20(RNAi) further induces autophagy in the spg-7(ad2249) background and found that knock-down of vps-4VPS4 and also vps-20CHMP6 leads to an increase in the average number of GFP::LGG-1GABARAP foci in hypodermal seam cells and intestinal cells (Fig 6A). Confirming an increase in autophagic flux, immunoblotting of GFP::LGG-1GABARAP in spg-7(ad2249) animals revealed increased levels of cleaved GFP upon vps-4(RNAi) or vps-20(RNAi) (~5.7-fold and ~3.7-fold, respectively; Fig 6B). Finally, we tested whether the loss of let-363mTOR, which induces autophagy and suppresses fzo-1(tm1133)-induced UPRmt (Fig 1A–1D), can suppress spg-7(ad2249)-induced UPRmt. Using the single-copy Phsp-6 mtHSP70gfp transgene bcSi9, we found that RNAi knock-down of let-363mTOR fails to suppress spg-7(ad2249)-induced UPRmt (Fig 6C and 6D). In summary, these results indicate that UPRmt induced by the loss of spg-7AFG3L2 is not suppressed by increasing autophagic flux. Based on these findings we propose that the induction of autophagy is sufficient to suppress UPRmt induced by a block in mitochondrial dynamics but not by the loss of spg-7AFG3L2.

Fig 6. Induction of autophagy is not sufficient to suppress spg-7(ad2249)-induced UPRmt.

Fig 6

(A) Plgg-1gfp::lgg-1 expression of spg-7(ad2249) L4 larvae in hypodermal seam cells and intestinal cells upon control(RNAi), vps-4(RNAi) or vps-20(RNAi). Representative images of >80 animals from three independent biological replicates are shown. Scale bar hypodermal seam cells: 5 μm. Scale bar intestinal cells: 20 μm. (B) Western blot analysis of cleaved GFP levels in spg-7(ad2249) upon control(RNAi), vps-4(RNAi) or vps-20(RNAi) using anti-GFP antibodies. Quantification of three independent experiments is shown. Values indicate means ± SD. (C) Fluorescence images of L4 larvae expressing Phsp-6gfp (bcSi9) in wild type (+/+) or spg-7(ad2249). L4 larvae were subjected to control(RNAi), atfs-1(RNAi) or let-363(RNAi) and the F1 generation was imaged. Scale bar: 200 μm. (D) Quantifications of fluorescence images from panel C. After subtracting the mean fluorescence intensity of wild type (+/+) on control(RNAi), the values were normalized to spg-7(ad2249) on control(RNAi). Each dot represents the quantification of fluorescence intensity of 15–20 L4 larvae. Values indicate means ± SD of 3 independent experiments in duplicates. ns: not significant, **P<0.01 using Kruskal-Wallis test with Dunn’s multiple comparison test to control(RNAi).

Defects in mitochondrial dynamics lead to changes in the levels of certain types of triacylglyerols, which can partially be reverted by induction of autophagy

To elucidate how the induction of autophagy leads to suppression of UPRmt in fzo-1(tm1133) and drp-1(tm1108) animals, we determined potential differences in metabolism in these genetic backgrounds. Since mitochondria and autophagy are known to regulate specific aspects of lipid metabolism, we performed non-targeted lipid profiling in fzo-1(tm1133), drp-1(tm1108) and spg-7(ad2249) mutant backgrounds and compared them to wild type.

Of the 5284 lipid ‘features’ detected, the levels of 3819 are changed in at least one of the three pairwise comparisons (fzo-1(tm1133) vs. wild type, drp-1(tm1108) vs. wild type, spg-7(ad2249) vs. wild type) (S8A Fig). Among the 3819 lipid features that are changed, 1774 are currently annotated as lipids. Interestingly, a third of the annotated lipids, whose levels were changed, are triacylglycerols (TGs). TGs are storage lipids and make up a major part of lipid droplets, which are broken down into fatty acids and subsequently oxidized in mitochondria upon energy demand [8284]. We initially determined the total amounts of TGs in the mutant backgrounds and compared them to that of wild type. Whereas drp-1(tm1108) mutants show an increase in the total amount of TGs, no changes are observed in fzo-1(tm1133) mutants and a decrease is detected in spg-7(ad2249) mutants (S8B Fig). To determine whether the amounts of TG species with a specific length of acyl chains and/or number of double bonds are altered, we plotted all 659 detected TGs and subsequently marked TGs that are specifically up- (red) or downregulated (blue) in fzo-1(tm1133), drp-1(tm1108) or spg-7(ad2249) animals (S8C Fig and S2 Table). Consistent with the observed decrease in the total amount of TGs, most of the individual TG species are downregulated in spg-7(ad2249) mutants (S8B and S8C Fig). In the drp-1(tm1108) background, TG species with altered levels initially showed no distinct pattern regarding length of acyl chains or degree of desaturation (S8C Fig and S2 Table). However, in the fzo-1(tm1133) background, these TG species can be separated into two clusters. Whereas TGs with shorter acyl chains are downregulated in fzo-1(tm1133) mutants, ‘longer’ TGs with a higher degree of unsaturation are increased (S8C Fig and S2 Table). Interestingly, when looking at the overlap between fzo-1(tm1133) and drp-1(tm1108), we observed a similar trend regarding changes in acyl length and desaturation for drp-1(tm1108) as well (S8D Fig and S2 Table).

Next, we tested whether the induction of autophagy can revert the specific changes in TG pattern observed in fzo-1(tm1133) mutants. Therefore, we knocked-down vps-4VPS4 or cogc-2COG2 to induce autophagy in fzo-1(tm1133) and wild-type animals and again, performed lipid profiling. We used principal component analysis (PCA) in order to show how distinct or similar the lipid profiles upon vps-4(RNAi) or cogc-2(RNAi) are. Interestingly, knock-down of vps-4VPS4 in either genotype was distinct from controls, which indicates major changes in the lipidome due to an efficient RNAi knock-down (Fig 7A). Moreover, we found that RNAi against cogc-2COG2 has only mild effects, since the samples cluster with controls in both genotypes. This might be attributed to a weak knock-down and most probably a weak induction of autophagy.

Fig 7. Induction of autophagy upon vps-4(RNAi) changes the levels of specific TGs in fzo-1(tm1133) mutants.

Fig 7

(A) Principal component analysis (PCA) scores plot of wild-type (+/+) and fzo-1(tm1133) animals subjected to control(RNAi), cogc-2(RNAi) or vps-4(RNAi). Turquois squares indicate internal quality controls (QC). (B) Scatterplot indicating the distribution and changes in the levels of TG species in fzo-1(tm1133) mutants in comparison to wild type (+/+). The x-axis labels the number of carbons (# of C) and the y-axis the number of double bonds (DB) in the acyl sidechains. The size of a dot indicates the number of detected isomers for a specific sum composition. Grey dots represent all detected TGs species and blue and red dots indicate down- (blue) or upregulation (red).

Subsequently, we specifically analyzed the TGs in fzo-1(tm1133) mutants on control(RNAi) and, consistent with our previous results (S8C Fig (left panel) and S2 Table), detected a decrease in the levels of TGs with shorter acyl chains while levels of TGs with longer chains increase, compared to wild type on control(RNAi) (Fig 7B (left panel) and S2 Table). The levels of TGs that are downregulated in the fzo-1(tm1133) background are either unchanged or further decreased upon depletion of vps-4VPS4 and the concomitant induction of autophagy (Fig 7B (middle panel) and S2 Table). In contrast, the levels of TGs that are upregulated in fzo-1(tm1133) animals are reduced upon induction of autophagy by knock-down of vps-4VPS4, although not always to the levels of wild type (Fig 7B (right panel) and S2 Table). Upon cogc-2(RNAi), we detected only minor effects on the levels of TGs in fzo-1(tm1133) (S9A Fig and S2 Table), which is consistent with the relatively small changes in the lipid profile as assessed by PCA (Fig 7A). However, the levels of most TGs that are decreased upon cogc-2(RNAi) are also decreased upon depletion of vps-4VPS4 (S9B Fig), suggesting that the induction of autophagy caused by the two different knock-downs leads to partially overlapping changes in the levels of TGs. Taken together, we find that the levels of specific TGs are changed in a similar manner in mutants with defects in mitochondrial dynamics. Moreover, we show that some of these changes can be reverted by the induction of autophagy in fzo-1(tm1133) animals.

Discussion

Induction of autophagy increases mitochondrial membrane potential and suppresses UPRmt in fzo-1(tm1133) mutants

We propose that the induction of autophagy partially restores membrane potential and thereby suppresses fzo-1(tm1133)-induced UPRmt. Interestingly, a decrease in mitochondrial membrane potential has recently been shown to be the signal for UPRmt induction [10]. Therefore, some aspect of mitochondrial stress that leads to both decreased membrane potential and the induction of UPRmt in fzo-1(tm1133) mutants can be rescued by the induction of autophagy in these animals. We were unable to verify our hypothesis since ESCRT-depleted fzo-1(tm1133); unc-51(e369) double mutants arrest during embryogenesis. This is in agreement with a study from Djeddi et al., which reported that induction of autophagy is a pro-survival mechanism in ESCRT-depleted animals [39]. Moreover, our data suggests that clearance of defective and depolarized mitochondria by pdr-1Parkin- or fndc-1FUNDC1,2-dependent mitophagy does not play a role in the suppression of fzo-1(tm1133)-induced UPRmt. In addition, we propose that the induction of autophagy may lead to increased organismal fitness, but that this effect is masked by pleiotropic effects upon knock-down of certain genes such as the ESCRT genes.

Increased autophagic flux compensates for a block in mitochondrial dynamics

We provide evidence that the induction of autophagy can also compensate for a block in mitochondrial fission and, hence, for defects in mitochondrial dynamics. In contrast, induction of autophagy does not suppress spg-7(ad2249)-induced UPRmt. Among the genes that suppress spg-7(ad2249)-induced UPRmt almost half have roles in translation or ribosome biogenesis, the knock-down of which may impair GFP synthesis by compromising cytosolic translation. Furthermore, we speculate that the knock-down of the remaining genes suppresses spg-7(ad2249)-induced UPRmt through mechanisms other than the induction of autophagy. This supports the notion that UPRmt induced by different types of mitochondrial stress are distinct in their mechanisms of induction and also in their mechanisms of suppression. In line with this, we found that different mitochondrial stresses have different impacts on the lipidome. Although FZO-1 and DRP-1 play different roles in mitochondrial dynamics, they have similar effects on the levels of many TGs when mutated. In contrast, the levels of these TGs are distinct in spg-7(ad2249) animals. The role of mitochondria in the metabolism of TGs is diverse. First, mitochondria are using fatty acids released from TGs upon lipolysis for energy production. Second, lipid droplet associated mitochondria deliver building blocks and energy for the synthesis of fatty acids and TGs. Fatty acids derived from this pathway typically show lower chain length and a higher degree of saturation [85]. Since we see a decrease in TGs with shorter chain length in fzo-1(tm1133) mutants, it is plausible that contact sites between lipid droplets and mitochondria are affected. Consistent with this, Benador et al. found high levels of MFN2 in lipid droplet associated mitochondria in brown adipose tissue of mice [85]. Furthermore, Rambold et al. reported that altered mitochondrial morphology in mouse embryonic fibroblasts lacking either Opa1 or Mfn1 affects fatty acid transfer from lipid droplets to mitochondria, thereby causing heterogeneous fatty acid distribution across the mitochondrial population [86]. Therefore, we speculate that the loss of fzo-1MFN or drp-1DRP1 but not spg-7AFG3L2 leads to alterations in contact sites between lipid droplets and mitochondria and that these alterations lead to specific changes in metabolism.

Interestingly, we found that increasing autophagic flux in fzo-1(tm1133) animals reverts some of the changes in the levels of TGs. Consistent with these results, autophagy has been shown to have a role in the breakdown of TGs from lipid droplets, which ensures a constant fatty acid supply to mitochondria for β-oxidation [87], highlighting the importance of autophagy in fatty acid metabolism. More recently, autophagy has also been shown to directly affect the levels of enzymes involved in β-oxidation by causing the degradation of the co-repressor of PPARα, a master regulator of lipid metabolism [88]. Therefore, we propose that the induction of autophagy in mutants with defects in mitochondrial dynamics results in elevated breakdown of specific TGs that are used to fuel mitochondrial metabolism, thereby leading to increased mitochondrial membrane potential and suppression of UPRmt.

Functional interactions between autophagy and UPRmt

Protection of mitochondrial and ultimately cellular homeostasis was previously proposed to be dependent on the integration of different mitochondrial and cellular stress pathways but experimental data so far was limited [89]. The first evidence that autophagy can affect UPRmt was the finding by Haynes et al. that knock-down of rheb-1RHEB, a known positive regulator of TOR [90], suppresses the Phsp-60 HSP60gfp reporter [13]. Two more recent studies reported contradictory results with respect to the effect of blocking mitophagy on UPRmt induction [7,91]. We demonstrate that a block in autophagy in the absence of mitochondrial stress induces UPRmt. Blocking autophagy results in major changes in metabolism [92,93] which may, to some extent, be caused by decreased delivery of lipids into mitochondria. This could consequently lead to the activation of UPRmt and thereby to a metabolic shift towards glycolysis [94]. Thus, fzo-1(tm1133) mutants, in which UPRmt is already activated, are less dependent on their mitochondria with regard to energy production and this might explain why blocking autophagy in these animals does not further increase UPRmt. Interestingly, based on our results, altering autophagy can influence UPRmt, but changes in UPRmt do not affect autophagy. In contrast, Guo et al. reported that upon mitochondrial stress, upregulation of both UPRmt and autophagy is dependent on ATFS-1ATF4,5 [40] and Nargund et al. showed that a small subset of autophagy related genes are upregulated via ATFS-1ATF4,5 upon mitochondrial stress (induced by spg-7(RNAi)) [11]. However, we show that import of ATFS-1ATF4,5 into the nucleus under conditions where mitochondrial stress is absent, is not sufficient to induce autophagy. Taken together, we found a previously undescribed functional connection between autophagy and UPRmt. We propose that the two pathways do not interact directly but that the induction of autophagy leads to improved mitochondrial function by affecting lipid metabolism and ameliorating cellular homeostasis, thereby suppressing UPRmt in mutants with defects in mitochondrial dynamics (Fig 8).

Fig 8. Autophagy compensates for defects in mitochondrial dynamics.

Fig 8

The disruption of mitochondrial dynamics leads to altered mitochondrial morphology and to activation of UPRmt and autophagy. We propose that in animals with compromised mitochondrial dynamics, the induction of autophagy fuels mitochondrial metabolism, thereby leading to increased mitochondrial membrane potential (ψ) and improved cellular homeostasis, which consequently results in suppression of UPRmt.

Genome-wide RNAi screen identifies a new autophagy network

In our dataset of 299 suppressors of fzo-1(tm1133)-induced UPRmt we found 143 genes that negatively regulate autophagy. Interestingly, 94% of these candidates (135/143) have orthologs in humans. We identified several components of the ubiquitin-proteasome system (UPS) (rpt-3PSMC4, rpn-13ADRM1, ufd-1UFD1, rbx-1RBX1, cul-1CUL1) [73,95,96] and found evidence in the literature that activation of autophagy compensates for the loss of the UPS [59,63]. Additionally, we identified several genes that are involved in cell signaling, e.g. ruvb-1RUVBL1, a component of the TOR pathway in C. elegans that induces autophagy when knocked-down [71]. Among the genes with roles in cellular trafficking, we found imb-2TNPO1,2, a regulator of the nuclear transport of DAF-16FOXO [70], which has been implicated in the regulation of autophagy [74]. Approximately one third of the candidates identified (44/143) are genes that regulate protein biosynthesis (S1 Table, GO categories ‘Ribosome Biogenesis’ and ‘Translation’), which was shown to be protective against mitochondrial stress when impaired [97]. Baker and colleagues showed that knock-down of protein kinases involved in translation, such as let-363mTOR, specifically suppress Phsp-60 HSP60gfp (zcIs9) expression. Based on our results, we propose that this effect could, to some extent, be due to the induction of autophagy. Taken together, we identified a broad range of cellular components and processes that all impact autophagy when deregulated, demonstrating the diverse and critical roles of autophagy in cellular homeostasis.

Conclusions

A block in mitochondrial dynamics leads to decreased mitochondrial membrane potential and the induction of UPRmt. Lipid profiling indicates that a block in mitochondrial dynamics also causes an increase in the levels of certain types of TGs, which is reversed by induction of autophagy. We propose that the breakdown of these TGs through an autophagy-dependent process leads to elevated metabolic activity and that this causes an increase in mitochondrial membrane potential and the suppression of UPRmt.

Methods

General C. elegans methods and strains

C. elegans strains were cultured as previously described [98]. Bristol N2 was used as the wild-type strain and the following alleles and transgenes were used: LGI: spg-7(ad2249) [41]; LGII: fzo-1(tm1133) (National BioResource Project), rrf-3(pk1426) [99], fndc-1(rny14) [78]; LGIII: pdr-1(lg103) [100]; LGIV: drp-1(tm1108) (National BioResource Project), bcSi9 (Phsp-6::gfp::unc-54 3’UTR) (this study), frIs7 (nlp-29p::GFP + col-12p::DsRed) [101]; LGV: unc-51(e369) [23], atfs-1(tm4525) (National BioResource Project), atfs-1(et15gf) [80]. Additionally, the following multi-copy integrated transgenes were used: adIs2122(lgg-1p::GFP::lgg-1 + rol-6(su1006)) [102], bpIs151 (sqst-1p::sqst-1::GFP + unc-76(+)) [51], zcIs9 (Phsp-60::gfp::unc-54 3’UTR) [14], zcIs13 (Phsp-6::gfp::unc-54 3’UTR) [14], zcIs18 (Pges-1::gfp(cyt)) [103], bcIs79 (Plet-858::gfpmt::let-858 3’UTR + rol-6(su1006)), bcIs78 (Pmyo-3::gfpmt::unc-54 3’UTR + rol-6(su1006)) [46]. The strains MOC92 bicIs10(hsp-1::tagRFP::unc-54 3’UTR) and MOC119 bicIs12(ttr-45p::tagRFP::ttr-45 3’UTR) were generated in the Casanueva lab by gonadal microinjection of plasmids pMOC1 and pMOC2, respectively followed by genome integration via UV irradiation using a Stratagene UV Crosslinker (Stratalinker) [104]. The irradiation dose was 35mJ/cm2 corresponding to Stratalinker power set up at 350. The single-copy integration allele bcSi9 was generated using MosSCI [105] of the plasmid pBC1516. The strain EG8081 (unc-119(ed3) III; oxTi177 IV) was used for targeted insertion on LGIV [106]. The strain MD2988 (Plet-858gfpmt) was generated by gonadal microinjection of the plasmid pBC938 followed by genome integration via EMS mutagenesis.

Plasmid construction

The plasmid pBC1516 was constructed using Gibson assembly [107]. The vector pCFJ350 (a gift from Erik Jorgensen; Addgene plasmid no. 34866) [108] was digested using AvrII. The putative hsp-6 promoter (1695bp upstream of the start codon of hsp-6) + 30 bp of the hsp-6 gene were PCR amplified from gDNA using overhang primers to pCFJ350 5’- acgtcaccggttctagatacTCGAGTCCATACAAGCACTC -3’ and gfp::unc-54 3’UTR 5’- ctttactcatGGAAGACAAGAATGATCGTG -3’ (lower case letters indicating overhangs). gfp::unc-54 3’UTR was PCR amplified from pPD95.77 using overhang primers to Phsp-6 5’- cttgtcttccATGAGTAAAGGAGAAGAACTTTTC -3’ and pCFJ350 5’- tagagggtaccagagctcacAAACAGTTATGTTTGGTATATTGG -3’ (lower case letters indicating overhangs).

The plasmid pBC938 was constructed using a classical cloning approach. Therefore, gfpmt was amplified by PCR from pBC307 (Phsgfpmt) [109] using the following primers carrying a NheI or KpnI restriction site, respectively:

mitogfpFKpnI: 5’- GGTACCATGGCACTCCTGCAATCAC -3’

mitogfpRNheI: 5’- GCTAGCCTATTTGTATAGTTCATCCATGC -3’

The amplified fragment was then digested with KpnI and NheI and subsequently ligated into the NheI and KpnI digested backbone L3786 (Plet-858NLS-GFP) (L3786 was a gift from Andrew Fire (Addgene plasmid # 1593; http://n2t.net/addgene:1593; RRID:Addgene_1593)).

The plasmids pMOC1 and pMOC2 were generated by Gibson cloning, using Gibson Assembly Master Mix (New England Biolabs E2611) according to standard protocol using the vector pTagRFP-C as backbone (Evrogen). For the plasmid pMOC1 (hsp-1p::tagRFP::unc-54 3’UTR)), the 1.3 kb intergenic region upstream hsp-1 was amplified and inserted at ScaI site, using the following primers:

hsp-1p fwd: 5’- GCCTCTAGAGTTACTTCGGCTCTATTACTG -3’

hsp-1p rev: 5’- tatcgcgagtTTTTACTGTAAAAAATAATTTAAAAATCAAGAAATAG -3’

The 3’UTR of unc-54 was amplified and inserted at XhoI site using the primers:

unc54UTR RFP fwd: 5’- CTTAATTaaAGGACTCAGATCgtccaattactcttcaacatc -3’

unc54UTR RFP rev: 5’- CAGAATTCGAAGCTTGAGCttcaaaaaaatttatcagaag -3’

For the plasmid pMOC2 (ttr-45p::tagRFP::ttr45 3’UTR), the 1.85 kb intergenic region upstream ttr-45 was amplified and inserted at XbaI site, using the following primers:

ttr-45p fwd: 5’- GCCTGCAGGCGCGCCTctgaaaaaaaatcatattacaaatcag -3’

ttr-45p rev: 5’- AGATATCGCGAGTACTtgaaattttaaattttgaattttagtc -3’

The 3’UTR of ttr-45, contained in the following primer (lower case) was inserted at the XhoI site:

ttr-45UTR:

5’- TTaaAGGACTCAGATCaataattttgattttatgtataataaagactttatctcggGCTCAAGCTTCGAATT -3’

RNA-mediated interference

RNAi by feeding was performed using the Ahringer RNAi library [45]. sorb-1(RNAi) was used as a negative control (referred to as ‘control(RNAi)’) in all RNAi experiments. For all experiments, except for the screens in fzo-1(tm1133), drp-1(tm1108) and spg-7(ad2249), RNAi clones were cultured overnight in 2 mL of LB carbenicillin (100 μg/mL) at 37°C and 200 rpm. The RNAi cultures were adjusted to 0.5 OD and 50 μL were used to seed 30 mm RNAi plates containing 6 mM IPTG. The plates were incubated at 20°C in the dark. 24 hours later, two L4 larvae of all wild-type strains or 16 L4 larvae of all strains carrying the fzo-1(tm1133) allele were inoculated onto the RNAi plates. L4 larvae of the F1 generation were collected after 4 days (wild-type strains) or 6–7 days (fzo-1(tm1133) mutants). hars-1(RNAi) was diluted 1:5 with sorb-1(RNAi) in all experiments. Larvae were imaged using M9 buffer with 150 mM sodium azide.

For the screens with the multi-copy zcIs13 transgene in fzo-1(tm1133), drp-1(tm1108) and spg-7(ad2249), RNAi clones were cultured overnight in 100 μL of LB carbenicillin (100 μg/mL) in a 96 well plate format at 37°C and 200 rpm. 10 μL of the RNAi cultures was used to seed 24 well RNAi plates containing 0.25% Lactose (w/v). The plates were incubated at 20°C in the dark. 24 hours later, 3 L4 larvae of all strains carrying the fzo-1(tm1133) and spg-7(ad2249) allele, and 2 L4 larvae of drp-1(tm1108) were inoculated onto the RNAi plates. The F1 generation was scored by eye for fluorescence intensity after 4–7 days.

Image acquisition, processing and analysis

For each RNAi condition, 10–20 animals were immobilized with M9 buffer containing 150 mM sodium azide on 2% agarose pads and imaged at 100x using a Leica GFP dissecting microscope (M205 FA) and the software Leica Application Suite (3.2.0.9652).

For image analysis, we used a Fiji-implemented macro using the IJ1 Macro language to automate the intensity measurement within defined areas of 2-dimensional images. An automated threshold using the Triangle method was applied to the fluorescence microscopy image, in order to generate a binary mask (The Triangle method was selected among the 16 available auto threshold methods of ImageJ as it provided the best results.). The mask was then inverted and the Particle Analyzer of ImageJ was used to remove noise by setting a minimum size (10 pixels) for objects to be included in the mask. After manually removing any remaining unwanted objects, the mask was applied to the corresponding fluorescent microscopy image and mean fluorescent intensity was measured. The mean fluorescent intensity outside the mask was defined as the background.

Mitochondrial morphology was assessed in a strain carrying bcIs78 and bcIs79 using a Zeiss Axioskop 2 and MetaMorph software (Molecular Devices).

TMRE staining and quantification

TMRE staining was performed with the F1 generation of respective RNAi treatments. L2 larvae were inoculated onto plates containing 0.1 μM TMRE (Thermo Life Sciences T669) and imaged in L4 stage using a 63x objective on Zeiss Axioskop 2 and MetaMorph software (Molecular Devices). Thereby TMRE is used in non-quenching mode and therefore suitable for quantifications and direct correlations to mitochondrial membrane potential.

The image is first converted to an 8-bit image, after which the continuous background signal is removed through background subtraction using the “rolling ball” algorithm with a ball radius of 15 pixels [110]. To remove remaining noise, two filters are applied. The first being a minimum filter with a value of 1, therefore replacing each pixel in the image with the smallest pixel value in a particular pixel’s neighborhood. This is followed by a mean filter with a radius of 2, which replaces each pixel with the neighborhood mean. Next, the Tubeness plugin is run with a sigma value of 1.0, which generates a score of how tube-like each point in the image is by using the eigenvalues of the Hessian matrix to calculate the measure of “tubeness” [111]. The resulting 32-bit image is converted back to 8-bit and an automatic threshold (using the IsoData algorithm) generates a binary mask. The final step involves the removal of any particles that are smaller than 10 pixels in size for they are assumed to be noise.

Raw image files are opened in parallel to their appendant binary masks (generated by the segmentation macro) and a mask-based selection is created in the raw image. Within this selection measurements are obtained in the raw image and collected for subsequent analysis.

Western blot analysis

Mixed-stage populations of worms were harvested, washed three times in M9 buffer, and the pellets were lysed in 2x Laemmli buffer. For analysis of the additional candidates (Fig 4) 60–80 L4 stage animals were picked for western blotting. For analysis of endogenous HSP-6, 100 L4 larvae were harvested per genotype. The protein extracts were separated by 10% SDS-PAGE and transferred to a PVDF membrane (0.45 μm pore, Merck Millipore). To detect GFP and Tubulin, we used primary anti-GFP (1:1000, Roche 11814460001) and primary anti-α-Tubulin (1:5000, Abcam ab7291) antibodies and secondary horseradish peroxidase-conjugated goat anti-mouse antibodies (BioRad #1706516). To detect endogenous HSP-6, we used anti-HSP-6 (1:10,000) as described previously [42] and secondary horseradish peroxidase-conjugated goat anti-rabbit antibodies (BioRad #1706515). Blots were developed using ECL (Amersham) or ECL Prime (Amersham) according to manufacturer’s protocol and images were quantified using the ChemiDoc XRS+ System (BioRad).

Analysis of autophagy and quantification of GFP::LGG-1 foci

L4 stage animals (except otherwise mentioned) were immobilized with M9 buffer containing 150 mM sodium azide on 2% agarose pads. Animals were imaged using a Leica TCS SP5 II confocal microscope (Leica Application Suite LAS software) with a 63x objective. GFP fluorescence was detected by excitation at 488 nm and emission at 507–518 nm. GFP::LGG-1 foci were counted in hypodermal seam cells on single images where the nucleus could clearly be seen. The amount of GFP::LGG-1 foci was counted in 2–5 seam cells per animal and the average number of GFP::LGG-1 foci per hypodermal seam cell was plotted for graphical representation and statistical analysis. SQST-1::GFP was imaged using Zeiss Axioskop 2 and MetaMorph software (Molecular Devices).

Analysis of thrashing rate

Body bends of L4 larvae were counted as previously described [75]. Briefly, the animals were transferred from the RNAi plates onto an empty NGM plate to get rid of all bacteria and then subsequently transferred into an empty petri dish filled with M9 buffer. After letting the L4 larvae adjust for one minute, they were recorded using a Samsung Galaxy S8 attached to a Leica MS5 stereomicroscope. The videos were played back at reduced speed using VLC media player (v3.0.8) and the number of body bends was counted manually for 1 minute.

Statistics

For experiments where two groups were compared, datasets were first tested for normality using Shapiro-Wilk normality test. If all samples of one dataset were found to be normally distributed, we conducted an unpaired two-tailed t-test. If samples were found to have non-equal variance, we conducted an unpaired tow-tailed t-test with Welch’s correction. For experiments where more than two groups were compared, datasets were first tested for normal distribution using Shapiro-Wilk normality test and then tested for equal variance using Brown-Forsythe test. If samples of one dataset were found to be normally distributed and to have equal variance, one-way ANOVA with Dunnett’s post hoc test was used to test for statistical significance with multiple comparisons to controls. If the dataset was not found to have normal distribution and/or have equal variance, Kruskal-Wallis test with Dunn’s post hoc test for multiple comparisons to controls was used.

Lipid profiling using UPLC-UHR-ToF-MS

RNAi in lipidomic experiments was performed using OP50(xu363), which is compatible for dsRNA production and delivery [112]. The L4440 plasmids containing the coding sequence of sorb-1, cogc-2 or vps-4 were purified from HT115 bacteria of the Ahringer library [45] using Qiagen Plasmid Mini Kit (Cat. No. 12125) and subsequently transformed into chemically competent OP50(xu363). Single clones were picked, sequenced and glycerol stocks were made for subsequent experiments. Bacterial clones were grown as described in section ‘RNA-mediated interference’ and 1 mL bacterial culture (OD600 = 0.5) was seeded onto 92 mm RNAi plates containing 1 mM IPTG. For sorb-1(RNAi) 120 L4 larvae, for vps-4(RNAi) 240 L4 larvae and for cogc-2(RNAi) 200 L4 larvae were transferred onto RNAi plates. Worms were collected in L4 stage after 6 days by washing the plates with MPEG. Worm pellets were subsequently washed using M9 and shock-frozen using liquid nitrogen and kept at -80°C until extraction.

Lipids were extracted using the BUME method [113]. Briefly, worms were resuspended in 50 μL MeOH and transferred to custom made bead beating tubes. Samples were homogenized at 8000 rpm in a Precellys Bead Beater for 3 times 10 seconds with 20 seconds breaks in between. The additional Cryolys module was used with liquid nitrogen to prevent excessive heating of samples during disruption. 150 μL butanol and 200 μL heptane-ethyl acetate (3:1) was added to each sample sequentially which were then incubated for 1 h at 500 rpm / RT. 200 μL 1% acetic acid was added to each sample followed by centrifugation for 15 min at 13000 rpm / 4˚C. The upper organic phase was transferred to a fresh Eppendorf tube and the lower aqueous phase was re-extracted by the addition of 200 μL heptane-ethyl acetate followed by incubation and centrifugation as described above. The upper organic phase was transferred to the already obtained organic phase. The lower phase was transferred to a new Eppendorf tube and used for metabolomic analyses. Samples were evaporated to dryness and stored at -20˚C. For lipidomics, samples were re-dissolved in 50 μL 65% isopropanol / 35% acetonitrile / 5% H2O, vortexed and 40 μL were transferred to an autosampler vial. The remaining 10 μL were pooled to form a QC sample for the entire study. The precipitated proteins in the aqueous phase were used for determination of protein content using a Bicinchoninic Acid Protein Assay Kit (Sigma-Aldrich, Taufkirchen, Germany).

Lipids were analyzed as previously described [114]. Briefly, lipids were separated on a Waters Acquity UPLC (Waters, Eschborn, Germany) using a Waters Cortecs C18 column (150 mm x 2.1 mm ID, 1.6 μm particle size, Waters, Eschborn Germany) and a linear gradient from 68% eluent A (40% H2O / 60% acetonitrile, 10 mM ammonium formate and 0.1% formic acid) to 97% eluent B (10% acetonitrile / 90% isopropanol, 10 mM ammonium formate and 0.1% formic acid). Mass spectrometric detection was performed using a Bruker maXis UHR-ToF-MS (Bruker Daltonic, Bremen, Germany) in positive ionization mode using data dependent acquisition to obtain MS1 and MS2 information. Every ten samples, a pooled QC was injected to check performance of the UPLC-UHR-ToF-MS system and used for normalization.

Raw data was processed with Genedata Expressionist for MS 13.0 (Genedata AG, Basel, Switzerland). Preprocessing steps included noise subtraction, m/z recalibration, chromatographic alignment and peak detection and grouping. Data was exported for Genedata Expressionist for MS 13.0 Analyst statistical analysis software and as .xlxs for further investigation. Maximum peak intensities were used for statistical analysis and data was normalized on the protein content of the sample and an intensity drift normalization based on QC samples was used to normalize for the acquisition sequence.

Lipid features that were detected in all pooled QC samples and had a relative standard deviation (RSD) < 30% were further investigated by statistical analysis. 5284 features passed this filter and the different mutants were compared against the wild-type control using Welch test. Lipids with a p-value < 0.05 were considered to be significantly changed.

Lipids were putatively annotated on the MS1 level using an in-house developed database for C. elegans lipids and bulk composition from LipidMaps [115], when available. Matching of MS2 spectra against an in-silico database of C. elegans lipids and LipidBlast was performed using the masstrixR package [116] (https://github.com/michaelwitting/masstrixR) and only hits with a forward and reverse matching score > 0.75 were considered. Annotations of interesting biological peaks were manually verified and corrected if necessary.

High throughput qRT-PCR on single worms using the Biomark system

cDNA from single worms was analyzed on the biomark system using Flex Six IFC. This nano-fluidic chip allows the comparison of 12 target genes across 36 individual worms per genotype. We monitored biological variability in gene expression of targets: endogenous hsp-6, hsp-60 and either bcSi9 single-copy or zcIs13 multi-copy transgenes. In addition, we monitored variability in gene expression of three “gold standard” control genes: either non-variable (hsp-1), medium variable (ttr-45) or highly variable (nlp-29). Ct values for all targets were normalized to the average of three housekeeping genes (cdc-42, ire-1 and pmp-3).

Design of qRT-PCR primers

Primers sets were designed to quantify C. elegans post-spliced transcripts. Primer sets were designed to span exon-exon junctions using NCBI Primer Blast software and subsequently blasted against the C. elegans genome to test for off-target complementarity. The list of qRT-PCR primers used with their PCR efficiency and coefficient of determination (R2) is shown in S3 Table.

Quantification of primer efficiency and specificity

Primers were selected for high PCR efficiency between 90 and 115%. To estimate primer efficiencies, a comprehensive titration of cDNA obtained from 500 ng of Trizol-extracted RNA was prepared within the range of linear amplification using a 1:2 series dilution. Each qRT-PCR reaction contained 1.5 μL of primer mix forward and reverse at 1.6 μM each, 3.5 μL of nuclease free water, 6 μL of 2X Platinum® SYBR® Green qPCR Supermix-UDG (Thermo Fisher Scientific PN 11744–500) and 1 μL of worm DNA lysate diluted or not. The qRT-PCR reactions were run on an iCycler system (Bio-Rad). PCR efficiencies were calculated by plotting the results of the titration of cDNA (Ct values versus log dilution) within the range of linear amplification. The efficiency was defined by the formula 100 x (10 (-1/slope)/2) with an optimal slope defined as -3.3 (1/3.3) = 2.

Worm synchronization

Worms were grown at 20°C and bleach synchronized. 36 worms per genotype were harvested at the L4.8/L4.9 stage based on vulval development [117], at about 48h post L1 plating for WT and about 65h post L1 plating for fzo-1(tm1133).

Worm lysis for total RNA preparation of single worm RNA

During harvesting, synchronized worms were individually picked into 10 μL lysis buffer (Power SYBR® Green Cells-to-CT kit, Thermo Fisher Scientific) in 8 strip PCR tubes. After harvesting the worms, the 8 strip PCR tubes were freeze-thawed 10 times by transferring tubes from a liquid nitrogen bath into a warm water bath (about 40ºC). Samples were vortexed during 20 minutes on a thermoblock set up at 4ºC. The samples were then quickly spun down and 1 μL of stop solution (Power SYBR Green Cells-to-CT kit, Thermo Fisher scientific) was added in each tube. The samples were then stored at -80ºC before further processing. Storage time was no more than one week before proceeding to reverse transcription.

Reverse transcription

Reverse Transcription PCR (RT-PCR) was performed by adding 5 μL of lysis mix (lysis buffer and stop solution) to 1.25 μL of Reverse Transcription Master Mix (Fluidigm PN 100–6297) into 96 well plates. We included one minus RT control per plate, containing 5 μL of lysis mix and 1.25 μL of RNase free water. Reverse Transcription cycling conditions were 25ºC for 5 min, 42ºC for 30 min and 85ºC for 5 min.

Pre-amplification

Pre-amplification was performed according to Fluidigm instruction manual: for every nano-fluidic chip, a pooled primer mix was prepared by adding 1 μL of primer stock (for every target gene to be tested on the chip) to water up to a final volume of 100 μL. Every primer stock contained both reverse and forward primers at a concentration of 50 μM each. A pre-amplification mix was prepared containing for each sample: 1 μL of PreAmp Master mix (Fluidigm PN 100–5744), 0.5 μL of pooled primer mix and 2.25 μL of nuclease free water. 3.75 μL of pre-amplification mix was then aliquoted in a 96 well-plate. 1.25 μL of cDNA was then added in each well. The samples were mixed by quick vortexing and centrifuged. Pre amplification conditions were the following: 95ºC for 2 min, 10 cycles of denaturation at 95ºC for 15 s followed by annealing/extension at 60ºC for 4 min.

Exo I treatment and sample dilution

To remove unincorporated primers, 2 μL of Exonuclease I mix was added to each pre-amplification reaction. The Exonuclease I mix contained 0.2 μL of Exonuclease I reaction buffer (New England BioLabs), 0.4 μL Exonuclease I at 20 Units/μL (New England BioLabs), and 1.4 μL of nuclease free water. The samples were incubated at 37ºC for 30 min followed by 15 min at 80ºC. The samples were finally diluted 1:5 by adding 18 μL of DNA suspension buffer (10 mM Tris, 0.1 mM EDTA, pH = 8.0, TEKnova PN-T0021).

Assay Mix preparation

For every pair of primers to be tested on the Fluidigm nano-fluidic chip, an assay mix was individually prepared on a 384 well PCR plate (for easier transfer to the Fluidigm nano-fluidic chips), typically the day before the experiment. Each assay mix (for 36 samples) contained 6.25 μL of 2X Assay loading reagent (Fluidigm PN 100–5359), 5 μL of DNA suspension buffer (10 mM Tris, 0.1 mM EDTA, pH = 8.0, TEKnova PN T0021), and 1.25 μL of primer stock (reverse and forward primers at a concentration of 50 μM each). Assay mixes were vortexed during 30 s minimum on a thermoblock set up at 4 ºC and centrifuged for 30 s minimum. 3 μL of each assay mix were loaded onto Flex Six Gene Expression IFC chips (Fluidigm PN 100–6308).

Sample Mix preparation

The samples mixes were prepared at the day of the experiment. 1.8 μL of diluted PreAmp and Exo I treated samples were added to a sample mix containing 2 μL of 2X SsoFast EvaGreen Supermix with Low ROX (Bio-Rad, PN 172–5211) and 0.2 μL of Flex Six Delta Gene Sample Reagent (Fluidigm PN 100–7673). 3 μL of each sample mix was loaded onto Flex Six IFC chips.

Biomark Run and data clean-up

Assay and sample mixes of Flex Six IFCs were loaded using a HX IFC controller (Fluidigm). The nano-fluidic chips were then run on a Biomark HD using the FlexSix Fast PCR+melt protocols. After the run, the data from every well on the plate was checked and cleaned up as following: samples for which all PCRs failed were eliminated. Any well, in which the melting peak temperature of a particular pair of primers was not as expected, was eliminated. It would happen occasionally, presumably when pairs of primers form dimers when target gene concentrations are very low, or from interactions of target primers with other primers in the pooled primer mix. Ct values were then normalized to the average of housekeeping genes and relative mRNA expression levels were calculated using the delta Ct method.

Determination of “Gold Standard” stable and variable transcripts

To validate our single-worm high throughput qRT-PCR method to monitor inter-individual variability in gene expression, we measured the coefficient of variation CV (CV = standard deviation/mean) for fluorescent transcriptional reporters of a stable gene MOC92 bicIs10(hsp-1p::tagRFP::unc-54 3'UTR) and of two variable transgenes MOC119 bicls12(ttr-45p::tagRFP::ttr45 3’UTR) (medium variable) and IG274 frIs7(nlp-29p::GFP; col-12p::DsRed) (highly variable). We verified that it matches the coefficient of variation calculated from normalized Ct values of endogenous transcripts hsp-1, ttr-45 and nlp-29 measured in our high-throughput single worm qPCR assay. Synchronized MOC92 and MOC119 transgenic worms were immobilized in M9 containing 3 mM Levamisole and imaged on a Nikon SMZ18 stereo epi-fluorescence microscope, while synchronized IG274 transgenic animals were mounted in 3 mM levamisole on a 2% agarose pad and imaged on a Nikon Ti Eclipse inverted microscope, as the fluorescence levels of the nlp-29 reporter in IG274 were too low to be imaged on the Nikon SMZ18. The fluorescence of each individual transgenic worm was quantified using Fiji software, by subtracting the background measurement from fluorescence measurements. The coefficient of variation was determined for synchronized population of day 2 animals (day 2 of adulthood: 74h post L1 plating at 20°C) for nlp-29 and ttr-45 reporters, while it was determined in day 1 synchronized animals (50h post L1 plating at 20°C) for hsp-1 reporter. The coefficient of variation is measured as follows:

  • bicIs10(hsp-1p::tagRFP::unc-54 3'UTR): 0.09< CV <0.14 (3 biological replicates)

  • bicls12(ttr-45p::tagRFP::ttr45 3’UTR): 0.31<CV<0.45 (3 biological replicates)

  • frIs7(nlp-29p::GFP; col-12p::DsRed): CV = 1.0 (1 biological replicate)

We observed a good correlation between the coefficient of variation for hsp-1, ttr-45 and nlp-29 transgenic reporters and the coefficient of variation for endogenous transcripts hsp-1, ttr-45 and nlp-29 measured by single worm qRT-PCR (S1F Fig).

Supporting information

S1 Fig. Comparison of expression levels and inter-individual variability of multi-copy Phsp-6 mtHSP70gfp (zcIs13) and single-copy integrated Phsp-6 mtHSP70gfp (bcSi9) transgenes.

(A) Brightfield (upper panel) and fluorescence images (lower panel) of L4 larvae expressing Phsp-6gfp (zcIs13) in wild type (+/+), spg-7(ad2249), fzo-1(tm1133) or drp-1(tm1108). Scale bar: 200 μm. (B) Brightfield (upper panel) and fluorescence images (lower panel) of L4 larvae expressing Phsp-6gfp (bcSi9) in wild type (+/+), spg-7(ad2249), fzo-1(tm1133) or drp-1(tm1108). Scale bar: 200 μm. (C) Quantifications of fluorescence images of panel A (Phsp-6gfp (zcIs13)) are shown. Each dot represents quantification of 15–20 L4 larvae. Values indicate means ± SD of ≥5 independent measurements. (D) Quantifications of fluorescence images of panel B (Phsp-6gfp (bcSi9)) are shown. Each dot represents quantification of 15–20 L4 larvae. Values indicate means ± SD of ≥4 independent measurements. (E) Quantifications of western blot analysis of endogenous HSP-6 levels in wild-type (+/+), spg-7(ad2249), fzo-1(tm1133) or drp-1(tm1108) using anti-HSP-6 antibodies. For each genotype, 100 L4 larvae were harvested per experiment for western blot analysis. Values indicate means of relative HSP-6 expression (HSP-6/TUB) ± SD, n = 2. (F) Inter-individual variability in gene expression of target genes in bcSi9 and zcIs13 in both wild type (+/+) and fzo-1(tm1133). To estimate inter-individual variability in gene expression, the coefficient of variation was calculated from individual mRNA levels obtained from normalized Ct values using the delta Ct method. Inter-individual variability values were normalized such that variability values for nlp-29 in wild type = 1 (bcSi9 or zcIs13). Number of individual worms: n = 35 (bcSi9), n = 32 (bcSi9; fzo-1(tm1133)), n = 31 (zcIs13), n = 31 (zcIs13; fzo-1(tm1133)).

(TIF)

S2 Fig. RNAi against vps-4VPS4 and vps-20CHMP6 suppresses expression of bcSi9 and induces autophagy in wild type (+/+).

(A) L4 larvae were subjected to control(RNAi), atfs-1(RNAi), vps-4(RNAi) or vps-20(RNAi) and the F1 generation was imaged. Each dot represents the quantification of fluorescence intensity of 15–20 L4 larvae. Values indicate means ± SD of 5 independent experiments in duplicates. *P<0.05, ***P<0.001 using one-way ANOVA with Dunnett’s multiple comparison test to control(RNAi). (B) Plgg-1gfp::lgg-1 expression of L4 larvae in hypodermal seam cells and intestinal cells upon control(RNAi), vps-4(RNAi) or vps-20(RNAi). Representative images of >30 animals from two independent biological replicates are shown. Scale bar hypodermal seam cells: 5 μm. Scale bar intestinal cells: 20 μm.

(TIF)

S3 Fig. Knock-down of ESCRT components in body wall muscle cells of wild type and intestinal cells in fzo-1(tm1133) does not change mitochondrial morphology.

(A) Fluorescence images of L4 larvae expressing Pmyo-3gfpmt in wild type (+/+). L4 larvae were subjected to control(RNAi), atfs-1(RNAi), vps-4(RNAi), vps-20(RNAi) or let-363(RNAi) and the F1 generation was imaged. Scale bar: 10 μm. (B) Fluorescence images of L4 larvae expressing Plet-858gfpmt in wild type (+/+) or fzo-1(tm1133). L4 larvae were subjected to control(RNAi), atfs-1(RNAi), vps-4(RNAi), vps-20(RNAi) or let-363(RNAi) and the F1 generation was imaged. Scale bar: 10 μm.

(TIF)

S4 Fig. Image segmentation and intensity measurement workflow.

A raw 16-bit image (1) is converted to 8-bit, followed by a background subtraction using the rolling ball algorithm (2). This is followed by the successive application of a minimum (3) and average filter (4). The ImageJ Tubeness plugin generates an image with object curvature scores (5), after which the IsoData autothresholding is applied to generate the binary mask (6). Noise is removed by filtering out particles below a certain size (7) and the final mask is used to define the area in which intensity measurements are obtained (8). Scale bar: 5 μm.

(TIF)

S5 Fig. Thrashing assay in wild-type and fzo-1(tm1133) animals upon induction of autophagy.

Thrashing rate was analyzed by counting body bends of animals swimming for 1 minute in M9 buffer in 3 independent experiments. Each dot represents one L4 larvae. (A) Thrashing rates of wild-type (+/+) or fzo-1(tm1133) L4 larvae. ****P<0.0001 using unpaired two-tailed t-test. n = 30. (B) Thrashing rates in wild-type animals upon induction of autophagy. L4 larvae were subjected to control(RNAi), vps-4(RNAi), vps-20(RNAi), let-363(RNAi) or hars-1(RNAi) and the F1 generation was analyzed. ns: not significant, ****P<0.0001 using Kruskal-Wallis test with Dunn’s multiple comparison test to control(RNAi). n = 30. (C) Thrashing rates in fzo-1(tm1133) animals upon induction of autophagy. L4 larvae were subjected to control(RNAi), vps-4(RNAi), vps-20(RNAi), let-363(RNAi) or hars-1(RNAi) and the F1 generation was analyzed. ns: not significant, ***P<0.001 using Kruskal-Wallis test with Dunn’s multiple comparison test to control(RNAi). n = 30.

(TIF)

S6 Fig. RNAi against vps-4VPS4 and vps-20CHMP6 does not suppress fzo-1(tm1133)-induced UPRmt when diluted with control(RNAi) or carried out in one generation from L2 to L4 larvae.

(A) Quantifications of fluorescence images of L4 larvae expressing Phsp-6gfp (bcSi9) in fzo-1(tm1133). Each ESCRT(RNAi) was diluted 1:1 with control(RNAi). After subtracting the mean fluorescence intensity of wild type (+/+) on control(RNAi), the values were normalized to fzo-1(tm1133) on control(RNAi). Each dot represents the quantification of fluorescence intensity of 15–20 L4 larvae. Values indicate means ± SD of 3 independent experiments in duplicates. ns: not significant, using one-way ANOVA with Dunnett’s multiple comparison test to control(RNAi). (B) Quantifications of fluorescence images of L4 larvae expressing Phsp-6gfp (bcSi9) in fzo-1(tm1133). L2 larvae were subjected to control(RNAi), atfs-1(RNAi), vps-4(RNAi) or vps-20(RNAi) and the same animals were imaged in L4 stage. After subtracting the mean fluorescence intensity of wild type (+/+) on control(RNAi), the values were normalized to fzo-1(tm1133) on control(RNAi). Each dot represents the quantification of fluorescence intensity of 15–20 L4 larvae. Values indicate means ± SD of 4 independent experiments in duplicates. ns: not significant, **P<0.01 using Kruskal-Wallis test with Dunn’s multiple comparison test to control(RNAi). (C) Plgg-1gfp::lgg-1 expression of fzo-1(tm1133) L4 larvae in hypodermal seam cells and intestinal cells. L2 larvae were subjected to control(RNAi), vps-4(RNAi) or vps-20(RNAi) and the same animals were imaged in L4 stage. Representative images of >60 animals from two independent biological replicates are shown. Scale bar hypodermal seam cells: 5 μm. Scale bar intestinal cells: 20 μm. (D) Quantifications of fluorescence images of L4 larvae expressing Phsp-6gfp (bcSi9) in fzo-1(tm1133) rrf-3(pk1426). L2 larvae were subjected to control(RNAi), atfs-1(RNAi), vps-4(RNAi) or vps-20(RNAi) and the same animals were imaged in L4 stage. After subtracting the mean fluorescence intensity of wild type (+/+) on control(RNAi), the values were normalized to fzo-1(tm1133) on control(RNAi). Each dot represents the quantification of fluorescence intensity of 15–20 L4 larvae. Values indicate means ± SD of 4 independent experiments in duplicates. ns: not significant, ****P<0.0001 using one-way ANOVA with Dunnett’s multiple comparison test to control(RNAi).

(TIF)

S7 Fig. Autophagy is induced in spg-7(ad2249) animals.

(A) Plgg-1gfp::lgg-1 expression in hypodermal seam cells of wild type (+/+) or spg-7(ad2249) L4 larvae. Scale bar: 5 μm. (B) Quantification of GFP::LGG-1 foci in hypodermal seam cells from panel A. Each dot represents the average amount of GFP::LGG-1 foci counted from 2–5 seam cells in one animal. n≥18 for each genotype; values indicate means ± SD; **P<0.01 using unpaired two-tailed t-test with Welch’s correction. (C) Nomarski and fluorescent images of the Psqst-1sqst-1::gfp translational reporter in embryos of wild type (+/+) and spg-7(ad2249) animals. As a positive control for a block in autophagy, unc-51(e369) was used. Representative images of >60 embryos are shown. Scale bar: 10 μm.

(TIF)

S8 Fig. Defects in mitochondrial homeostasis lead to major changes in lipid metabolism.

(A) Venn diagrams showing the overlap of lipids up- or downregulated in fzo-1(tm1133), drp-1(tm1108) and spg-7(ad2249) in comparison to wild type (+/+). (B) Total amount of TGs in wild type (+/+), fzo-1(tm1133), drp-1(tm1108) and spg-7(ad2249) backgrounds. Means ± SD are shown; ns: not significant, *P<0.05, ****P<0.0001 using Welch test. (C) Scatterplot indicating the distribution and changes in the levels of TG species in the different mutants in comparison to wild type (+/+). (D)) Scatterplot indicating the overlap of the changes in the levels of TG species of fzo-1(tm1133) and drp-1(tm1108) mutants in comparison to wild type (+/+). (C) and (D) The x-axis labels the number of carbons (# of C) and the y-axis the number of double bonds (DB) in the acyl sidechains. The size of a dot indicates the number of detected isomers for a specific sum composition. Grey dots represent all detected TGs species and blue and red dots indicate down- (blue) or upregulation (red).

(TIF)

S9 Fig. Induction of autophagy upon cogc-2(RNAi) changes the levels of specific TGs in fzo-1(tm1133) mutants.

(A) Scatterplot indicating the distribution and changes in the level of TG species in fzo-1(tm1133) mutants in comparison to wild type (+/+). The x-axis labels the number of carbons (# of C) and the y-axis the number of double bonds (DB) in the acyl sidechains. The size of a dot indicates the number of detected isomers for a specific sum composition. Grey dots represent all detected TGs species and blue and red dots indicate down- (blue) or upregulation (red). (B) Venn diagram indicating the overlap of TG species downregulated (left panel) or upregulated (right panel) in fzo-1(tm1133) and downregulated upon vps-4(RNAi) or cogc-2(RNAi).

(TIF)

S1 Table. List of genes that suppress fzo-1(lf)-induced UPRmt and induce autophagy in wild-type animals upon knock-down.

Candidate genes were identified in the primary RNAi-screen using fzo-1(tm1133), subsequently knocked-down and tested for induction of autophagy and re-screened for UPRmt suppression in two different mutant backgrounds: drp-1(tm1108) and spg-7(ad2249).

(XLSX)

S2 Table. Numerical data of lipidomic experiments.

Significantly up- or downregulated lipids in fzo-1(tm1133), drp-1(tm1108) or spg-7(ad2249) mutants (Sheet 1), significantly up- or downregulated TGs in fzo-1(tm1133), drp-1(tm1108) or spg-7(ad2249) mutants (Sheet 2) and significantly up- or downregulated TGs in fzo-1(tm1133) upon induction of autophagy by vps-4(RNAi) or cogc-2(RNAi) (Sheet 3). MS1 annotations, P-values and fold change are indicated.

(XLSX)

S3 Table. List of qRT-PCR primers.

Primers used for qRT-PCR including PCR efficiency and coefficient of determination (R2).

(XLSX)

Acknowledgments

We thank Eric Lambie, Dejana Mokranjac, the ‘Mito Club’ and members of the Conradt lab for discussion and comments on the manuscript. We thank M. Bauer, L. Jocham, N. Lebedeva and M. Schwarz for excellent technical support and S. Mitani (National BioResource Project, Tokyo, Japan) for fzo-1(tm1133), drp-1(tm1108) and atfs-1(tm4525). We thank Keith Nehrke and Vincent Galy for fndc-1(rny-14). Some strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440).

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

This work was supported by the Deutsche Forschungsgemeinschaft https://eur01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.dfg.de%2Fen%2F&data=02%7C01%7C%7C381f38b59bcd4e9a567f08d7bba8aec2%7C1faf88fea9984c5b93c9210a11d9a5c2%7C0%7C0%7C637184205470464132&sdata=Eb4roXJqDx7UamjpWqYooqGw6RKzo5yD8jDFkLtapls%3D&reserved=0 (CO204/6-1, CO204/9-1 and EXC114 to BC). Some strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs https://eur01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.nih.gov%2F&data=02%7C01%7C%7C381f38b59bcd4e9a567f08d7bba8aec2%7C1faf88fea9984c5b93c9210a11d9a5c2%7C0%7C0%7C637184205470464132&sdata=LGLqn8cL5mhk9Xn6gWttZPV5hOmsiv%2Fi13%2BC6CDBYPU%3D&reserved=0 (P40 OD010440). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Youle RJ, van der Bliek AM. Mitochondrial fission, fusion, and stress. Science (New York, NY). 2012;337(6098):1062–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.van der Bliek AM, Shen Q, Kawajiri S. Mechanisms of Mitochondrial Fission and Fusion. Cold Spring Harbor Perspectives in Biology. 2013;5(6). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Labrousse AM, Zappaterra MD, Rube DA, van der Bliek AM. C. elegans Dynamin-Related Protein DRP-1 Controls Severing of the Mitochondrial Outer Membrane. Molecular cell. 1999;4(5):815–26. 10.1016/s1097-2765(00)80391-3 [DOI] [PubMed] [Google Scholar]
  • 4.Ingerman E, Perkins EM, Marino M, Mears JA, McCaffery JM, Hinshaw JE, et al. Dnm1 forms spirals that are structurally tailored to fit mitochondria. The Journal of cell biology. 2005;170(7):1021–7. 10.1083/jcb.200506078 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Ichishita R, Tanaka K, Sugiura Y, Sayano T, Mihara K, Oka T. An RNAi Screen for Mitochondrial Proteins Required to Maintain the Morphology of the Organelle in Caenorhabditis elegans. The Journal of Biochemistry. 2008;143(4):449–54. 10.1093/jb/mvm245 [DOI] [PubMed] [Google Scholar]
  • 6.Kanazawa T, Zappaterra MD, Hasegawa A, Wright AP, Newman-Smith ED, Buttle KF, et al. The C. elegans Opa1 Homologue EAT-3 Is Essential for Resistance to Free Radicals. PLoS genetics. 2008;4(2):e1000022 10.1371/journal.pgen.1000022 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Kim S, Sieburth D. Sphingosine Kinase Activates the Mitochondrial Unfolded Protein Response and Is Targeted to Mitochondria by Stress. Cell reports. 2018;24(11):2932–45.e4. 10.1016/j.celrep.2018.08.037 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Zhang Q, Wu X, Chen P, Liu L, Xin N, Tian Y, et al. The Mitochondrial Unfolded Protein Response Is Mediated Cell-Non-autonomously by Retromer-Dependent Wnt Signaling. Cell. 2018;174(4):870–83.e17. 10.1016/j.cell.2018.06.029 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Haynes CM, Yang Y, Blais SP, Neubert TA, Ron D. The matrix peptide exporter HAF-1 signals a mitochondrial UPR by activating the transcription factor ZC376.7 in C. elegans. Molecular cell. 2010;37(4):529–40. 10.1016/j.molcel.2010.01.015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Rolland SG, Schneid S, Schwarz M, Rackles E, Fischer C, Haeussler S, et al. Compromised Mitochondrial Protein Import Acts as a Signal for UPRmt. Cell reports. 2019;28(7):1659–69.e5. 10.1016/j.celrep.2019.07.049 [DOI] [PubMed] [Google Scholar]
  • 11.Nargund AM, Pellegrino MW, Fiorese CJ, Baker BM, Haynes CM. Mitochondrial import efficiency of ATFS-1 regulates mitochondrial UPR activation. Science (New York, NY). 2012;337(6094):587–90. 10.1126/science.1223560 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Benedetti C, Haynes CM, Yang Y, Harding HP, Ron D. Ubiquitin-like protein 5 positively regulates chaperone gene expression in the mitochondrial unfolded protein response. Genetics. 2006;174(1):229–39. 10.1534/genetics.106.061580 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Haynes CM, Petrova K, Benedetti C, Yang Y, Ron D. ClpP mediates activation of a mitochondrial unfolded protein response in C. elegans. Developmental cell. 2007;13(4):467–80. 10.1016/j.devcel.2007.07.016 [DOI] [PubMed] [Google Scholar]
  • 14.Yoneda T, Benedetti C, Urano F, Clark SG, Harding HP, Ron D. Compartment-specific perturbation of protein handling activates genes encoding mitochondrial chaperones. Journal of cell science. 2004;117(Pt 18):4055–66. [DOI] [PubMed] [Google Scholar]
  • 15.Levine B, Klionsky DJ. Development by Self-Digestion. Developmental cell. 2004;6(4):463–77. 10.1016/s1534-5807(04)00099-1 [DOI] [PubMed] [Google Scholar]
  • 16.Mizushima N. Autophagy: process and function. Genes Dev. 2007;21(22):2861–73. 10.1101/gad.1599207 [DOI] [PubMed] [Google Scholar]
  • 17.Feng Y, He D, Yao Z, Klionsky DJ. The machinery of macroautophagy. Cell Res. 2014;24(1):24–41. 10.1038/cr.2013.168 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Nakatogawa H, Suzuki K, Kamada Y, Ohsumi Y. Dynamics and diversity in autophagy mechanisms: lessons from yeast. Nature reviews Molecular cell biology. 2009;10(7):458–67. 10.1038/nrm2708 [DOI] [PubMed] [Google Scholar]
  • 19.Long X, Spycher C, Han ZS, Rose AM, Müller F, Avruch J. TOR Deficiency in C. elegans Causes Developmental Arrest and Intestinal Atrophy by Inhibition of mRNA Translation. Current Biology. 2002;12(17):1448–61. 10.1016/s0960-9822(02)01091-6 [DOI] [PubMed] [Google Scholar]
  • 20.Hansen M, Chandra A, Mitic LL, Onken B, Driscoll M, Kenyon C. A role for autophagy in the extension of lifespan by dietary restriction in C. elegans. PLoS genetics. 2008;4(2):e24 10.1371/journal.pgen.0040024 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Jia K, Chen D, Riddle DL. The TOR pathway interacts with the insulin signaling pathway to regulate C. elegans larval development, metabolism and life span. Development. 2004;131(16):3897–906. 10.1242/dev.01255 [DOI] [PubMed] [Google Scholar]
  • 22.Kuroyanagi H, Yan J, Seki N, Yamanouchi Y, Suzuki Y, Takano T, et al. Human ULK1, a novel serine/threonine kinase related to UNC-51 kinase of Caenorhabditis elegans: cDNA cloning, expression, and chromosomal assignment. Genomics. 1998;51(1):76–85. 10.1006/geno.1998.5340 [DOI] [PubMed] [Google Scholar]
  • 23.Ogura K, Wicky C, Magnenat L, Tobler H, Mori I, Müller F, et al. Caenorhabditis elegans unc-51 gene required for axonal elongation encodes a novel serine/threonine kinase. Genes & Development. 1994;8(20):2389–400. [DOI] [PubMed] [Google Scholar]
  • 24.Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell. 2006;124(3):471–84. 10.1016/j.cell.2006.01.016 [DOI] [PubMed] [Google Scholar]
  • 25.Tsukada M, Ohsumi Y. Isolation and characterization of autophagy-defective mutants of Saccharomyces cerevisiae. FEBS Letters. 1993;333(1–2):169–74. 10.1016/0014-5793(93)80398-e [DOI] [PubMed] [Google Scholar]
  • 26.Sato M, Sato K. Degradation of Paternal Mitochondria by Fertilization-Triggered Autophagy in C. elegans Embryos. Science (New York, NY). 2011;334(6059):1141–4. [DOI] [PubMed] [Google Scholar]
  • 27.Christ L, Raiborg C, Wenzel EM, Campsteijn C, Stenmark H. Cellular Functions and Molecular Mechanisms of the ESCRT Membrane-Scission Machinery. Trends in biochemical sciences. 2017;42(1):42–56. 10.1016/j.tibs.2016.08.016 [DOI] [PubMed] [Google Scholar]
  • 28.Katzmann DJ, Babst M, Emr SD. Ubiquitin-Dependent Sorting into the Multivesicular Body Pathway Requires the Function of a Conserved Endosomal Protein Sorting Complex, ESCRT-I. Cell. 2001;106(2):145–55. 10.1016/s0092-8674(01)00434-2 [DOI] [PubMed] [Google Scholar]
  • 29.Raiborg C, Bache KG, Gillooly DJ, Madshus IH, Stang E, Stenmark H. Hrs sorts ubiquitinated proteins into clathrin-coated microdomains of early endosomes. Nature cell biology. 2002;4(5):394–8. 10.1038/ncb791 [DOI] [PubMed] [Google Scholar]
  • 30.Sachse M, Urbe S, Oorschot V, Strous GJ, Klumperman J. Bilayered clathrin coats on endosomal vacuoles are involved in protein sorting toward lysosomes. Mol Biol Cell. 2002;13(4):1313–28. 10.1091/mbc.01-10-0525 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Amit I, Yakir L, Katz M, Zwang Y, Marmor MD, Citri A, et al. Tal, a Tsg101-specific E3 ubiquitin ligase, regulates receptor endocytosis and retrovirus budding. Genes Dev. 2004;18(14):1737–52. 10.1101/gad.294904 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Carlton JG, Martin-Serrano J. Parallels between cytokinesis and retroviral budding: a role for the ESCRT machinery. Science (New York, NY). 2007;316(5833):1908–12. [DOI] [PubMed] [Google Scholar]
  • 33.Filimonenko M, Stuffers S, Raiborg C, Yamamoto A, Malerod L, Fisher EM, et al. Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease. The Journal of cell biology. 2007;179(3):485–500. 10.1083/jcb.200702115 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Lee JA, Beigneux A, Ahmad ST, Young SG, Gao FB. ESCRT-III dysfunction causes autophagosome accumulation and neurodegeneration. Curr Biol. 2007;17(18):1561–7. 10.1016/j.cub.2007.07.029 [DOI] [PubMed] [Google Scholar]
  • 35.Rusten TE, Vaccari T, Lindmo K, Rodahl LM, Nezis IP, Sem-Jacobsen C, et al. ESCRTs and Fab1 regulate distinct steps of autophagy. Curr Biol. 2007;17(20):1817–25. 10.1016/j.cub.2007.09.032 [DOI] [PubMed] [Google Scholar]
  • 36.Tamai K, Tanaka N, Nara A, Yamamoto A, Nakagawa I, Yoshimori T, et al. Role of Hrs in maturation of autophagosomes in mammalian cells. Biochem Biophys Res Commun. 2007;360(4):721–7. 10.1016/j.bbrc.2007.06.105 [DOI] [PubMed] [Google Scholar]
  • 37.Takahashi Y, He H, Tang Z, Hattori T, Liu Y, Young MM, et al. An autophagy assay reveals the ESCRT-III component CHMP2A as a regulator of phagophore closure. Nature communications. 2018;9(1):2855 10.1038/s41467-018-05254-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Zhou F, Wu Z, Zhao M, Murtazina R, Cai J, Zhang A, et al. Rab5-dependent autophagosome closure by ESCRT. The Journal of cell biology. 2019;218(6):1908–27. 10.1083/jcb.201811173 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Djeddi A, Michelet X, Culetto E, Alberti A, Barois N, Legouis R. Induction of autophagy in ESCRT mutants is an adaptive response for cell survival in C. elegans. Journal of cell science. 2012;125(3):685–94. [DOI] [PubMed] [Google Scholar]
  • 40.Guo B, Huang X, Zhang P, Qi L, Liang Q, Zhang X, et al. Genome‐wide screen identifies signaling pathways that regulate autophagy during Caenorhabditis elegans development. EMBO reports. 2014;15(6):705–13. 10.1002/embr.201338310 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Zubovych IO, Straud S, Roth MG, Newmeyer DD. Mitochondrial Dysfunction Confers Resistance to Multiple Drugs in Caenorhabditis elegans. Molecular Biology of the Cell. 2010;21(6):956–69. 10.1091/mbc.E09-08-0673 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Köhler F, Müller-Rischart AK, Conradt B, Rolland SG. The loss of LRPPRC function induces the mitochondrial unfolded protein response. Aging. 2015;7(9):701–12. 10.18632/aging.100812 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Liu Y, Samuel BS, Breen PC, Ruvkun G. Caenorhabditis elegans pathways that surveil and defend mitochondria. Nature. 2014;508(7496):406–10. 10.1038/nature13204 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Runkel ED, Liu S, Baumeister R, Schulze E. Surveillance-activated defenses block the ROS-induced mitochondrial unfolded protein response. PLoS genetics. 2013;9(3):e1003346 10.1371/journal.pgen.1003346 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Kamath RS, Ahringer J. Genome-wide RNAi screening in Caenorhabditis elegans. Methods (San Diego, Calif). 2003;30(4):313–21. [DOI] [PubMed] [Google Scholar]
  • 46.Rolland SG, Motori E, Memar N, Hench J, Frank S, Winklhofer KF, et al. Impaired complex IV activity in response to loss of LRPPRC function can be compensated by mitochondrial hyperfusion. Proceedings of the National Academy of Sciences of the United States of America. 2013;110(32):E2967–76. 10.1073/pnas.1303872110 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Loew LM, Tuft RA, Carrington W, Fay FS. Imaging in five dimensions: time-dependent membrane potentials in individual mitochondria. Biophysical Journal. 1993;65(6):2396–407. 10.1016/S0006-3495(93)81318-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Chen Y, Scarcelli V, Legouis R. Approaches for Studying Autophagy in Caenorhabditis elegans. Cells. 2017;6(3). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Jenzer C, Simionato E, Legouis R. Tools and methods to analyze autophagy in C. elegans. Methods (San Diego, Calif). 2015;75:162–71. [DOI] [PubMed] [Google Scholar]
  • 50.Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 2016;12(1):1–222. 10.1080/15548627.2015.1100356 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Tian Y, Li Z, Hu W, Ren H, Tian E, Zhao Y, et al. C. elegans Screen Identifies Autophagy Genes Specific to Multicellular Organisms. Cell. 2010;141(6):1042–55. 10.1016/j.cell.2010.04.034 [DOI] [PubMed] [Google Scholar]
  • 52.Zhang H, Chang JT, Guo B, Hansen M, Jia K, Kovacs AL, et al. Guidelines for monitoring autophagy in Caenorhabditis elegans. Autophagy. 2015;11(1):9–27. 10.1080/15548627.2014.1003478 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Chapin HC, Okada M, Merz AJ, Miller DL. Tissue-specific autophagy responses to aging and stress in C. elegans. Aging (Albany NY). 2015;7(6):419–34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Mizushima N, Yoshimori T, Levine B. Methods in Mammalian Autophagy Research. Cell. 2010;140(3):313–26. 10.1016/j.cell.2010.01.028 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Homma K, Suzuki K, Sugawara H. The Autophagy Database: an all-inclusive information resource on autophagy that provides nourishment for research. Nucleic Acids Research. 2011;39(suppl_1):D986–D90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Lipinski MM, Hoffman G, Ng A, Zhou W, Py BF, Hsu E, et al. A genome-wide siRNA screen reveals multiple mTORC1 independent signaling pathways regulating autophagy under normal nutritional conditions. Developmental cell. 2010;18(6):1041–52. 10.1016/j.devcel.2010.05.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Strohecker AM, Joshi S, Possemato R, Abraham RT, Sabatini DM, White E. Identification of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase as a novel autophagy regulator by high content shRNA screening. Oncogene. 2015;34(45):5662–76. 10.1038/onc.2015.23 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Dayalan Naidu S, Dikovskaya D, Gaurilcikaite E, Knatko EV, Healy ZR, Mohan H, et al. Transcription factors NRF2 and HSF1 have opposing functions in autophagy. Sci Rep. 2017;7(1):11023 10.1038/s41598-017-11262-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Demishtein A, Fraiberg M, Berko D, Tirosh B, Elazar Z, Navon A. SQSTM1/p62-mediated autophagy compensates for loss of proteasome polyubiquitin recruiting capacity. Autophagy. 2017;13(10):1697–708. 10.1080/15548627.2017.1356549 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Dokladny K, Zuhl MN, Mandell M, Bhattacharya D, Schneider S, Deretic V, et al. Regulatory coordination between two major intracellular homeostatic systems: heat shock response and autophagy. The Journal of biological chemistry. 2013;288(21):14959–72. 10.1074/jbc.M113.462408 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Hu G, McQuiston T, Bernard A, Park YD, Qiu J, Vural A, et al. A conserved mechanism of TOR-dependent RCK-mediated mRNA degradation regulates autophagy. Nature cell biology. 2015;17(7):930–42. 10.1038/ncb3189 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Hwang DW, So KS, Kim SC, Park KM, Lee YJ, Kim SW, et al. Autophagy Induced by CX-4945, a Casein Kinase 2 Inhibitor, Enhances Apoptosis in Pancreatic Cancer Cell Lines. Pancreas. 2017;46(4):575–81. 10.1097/MPA.0000000000000780 [DOI] [PubMed] [Google Scholar]
  • 63.Keith SA, Maddux SK, Zhong Y, Chinchankar MN, Ferguson AA, Ghazi A, et al. Graded Proteasome Dysfunction in Caenorhabditis elegans Activates an Adaptive Response Involving the Conserved SKN-1 and ELT-2 Transcription Factors and the Autophagy-Lysosome Pathway. PLoS genetics. 2016;12(2):e1005823 10.1371/journal.pgen.1005823 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Kumsta C, Chang JT, Schmalz J, Hansen M. Hormetic heat stress and HSF-1 induce autophagy to improve survival and proteostasis in C. elegans. Nature communications. 2017;8:14337 10.1038/ncomms14337 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Lee SW, Song YS, Lee SY, Yoon YG, Lee SH, Park BS, et al. Downregulation of protein kinase CK2 activity facilitates tumor necrosis factor-alpha-mediated chondrocyte death through apoptosis and autophagy. PloS one. 2011;6(4):e19163 10.1371/journal.pone.0019163 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Meléndez A, Tallóczy Z, Seaman M, Eskelinen E-L, Hall DH, Levine B. Autophagy Genes Are Essential for Dauer Development and Life-Span Extension in C. elegans. Science (New York, NY). 2003;301(5638):1387–91. [DOI] [PubMed] [Google Scholar]
  • 67.Menzies FM, Garcia-Arencibia M, Imarisio S, O'Sullivan NC, Ricketts T, Kent BA, et al. Calpain inhibition mediates autophagy-dependent protection against polyglutamine toxicity. Cell death and differentiation. 2015;22(3):433–44. 10.1038/cdd.2014.151 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Murphy CT, McCarroll SA, Bargmann CI, Fraser A, Kamath RS, Ahringer J, et al. Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans. Nature. 2003;424:277 10.1038/nature01789 [DOI] [PubMed] [Google Scholar]
  • 69.Pierce SB, Costa M, Wisotzkey R, Devadhar S, Homburger SA, Buchman AR, et al. Regulation of DAF-2 receptor signaling by human insulin and ins-1, a member of the unusually large and diverse C. elegans insulin gene family. Genes & Development. 2001;15(6):672–86. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Putker M, Madl T, Vos Harmjan R, de Ruiter H, Visscher M, van den Berg Maaike CW, et al. Redox-Dependent Control of FOXO/DAF-16 by Transportin-1. Molecular cell. 2013;49(4):730–42. 10.1016/j.molcel.2012.12.014 [DOI] [PubMed] [Google Scholar]
  • 71.Sheaffer KL, Updike DL, Mango SE. The Target of Rapamycin pathway antagonizes pha-4/FoxA to control development and aging. Curr Biol. 2008;18(18):1355–64. 10.1016/j.cub.2008.07.097 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Tang L, Fares H, Zhao X, Du W, Liu BF. Different endocytic functions of AGEF-1 in C. elegans coelomocytes. Biochimica et biophysica acta. 2012;1820(7):829–40. 10.1016/j.bbagen.2012.03.004 [DOI] [PubMed] [Google Scholar]
  • 73.Yang D, Li L, Liu H, Wu L, Luo Z, Li H, et al. Induction of autophagy and senescence by knockdown of ROC1 E3 ubiquitin ligase to suppress the growth of liver cancer cells. Cell death and differentiation. 2013;20(2):235–47. 10.1038/cdd.2012.113 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Zhao Y, Yang J, Liao W, Liu X, Zhang H, Wang S, et al. Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity. Nature cell biology. 2010;12:665 10.1038/ncb2069 [DOI] [PubMed] [Google Scholar]
  • 75.Nawa M, Kage-Nakadai E, Aiso S, Okamoto K, Mitani S, Matsuoka M. Reduced expression of BTBD10, an Akt activator, leads to motor neuron death. Cell Death & Differentiation. 2012;19(8):1398–407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Nawa M, Matsuoka M. The Method of the Body Bending Assay Using Caenorhabditis elegans. Bio Protoc. 2012;2(17):e253. [Google Scholar]
  • 77.Johnson D, Nehrke K. Mitochondrial Fragmentation Leads to Intracellular Acidification in Caenorhabditis elegans and Mammalian Cells. Molecular Biology of the Cell. 2010;21(13):2191–201. 10.1091/mbc.E09-10-0874 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Lim Y, Rubio-Peña K, Sobraske PJ, Molina PA, Brookes PS, Galy V, et al. Fndc-1 contributes to paternal mitochondria elimination in C. elegans. Developmental Biology. 2019;454(1):15–20. 10.1016/j.ydbio.2019.06.016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Palikaras K, Lionaki E, Tavernarakis N. Coordination of mitophagy and mitochondrial biogenesis during ageing in C. elegans. Nature. 2015. [DOI] [PubMed] [Google Scholar]
  • 80.Rauthan M, Ranji P, Aguilera Pradenas N, Pitot C, Pilon M. The mitochondrial unfolded protein response activator ATFS-1 protects cells from inhibition of the mevalonate pathway. Proceedings of the National Academy of Sciences of the United States of America. 2013;110(15):5981–6. 10.1073/pnas.1218778110 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Bennett CF, Vander Wende H, Simko M, Klum S, Barfield S, Choi H, et al. Activation of the mitochondrial unfolded protein response does not predict longevity in Caenorhabditis elegans. Nature communications. 2014;5:3483 10.1038/ncomms4483 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Buis A, Bellemin S, Goudeau J, Monnier L, Loiseau N, Guillou H, et al. Coelomocytes Regulate Starvation-Induced Fat Catabolism and Lifespan Extension through the Lipase LIPL-5 in Caenorhabditis elegans. Cell reports. 2019;28(4):1041–9.e4. 10.1016/j.celrep.2019.06.064 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Harvald EB, Sprenger RR, Dall KB, Ejsing CS, Nielsen R, Mandrup S, et al. Multi-omics Analyses of Starvation Responses Reveal a Central Role for Lipoprotein Metabolism in Acute Starvation Survival in C.elegans. Cell Systems. 2017;5(1):38–52.e4. 10.1016/j.cels.2017.06.004 [DOI] [PubMed] [Google Scholar]
  • 84.Vrablik TL, Petyuk VA, Larson EM, Smith RD, Watts JL. Lipidomic and proteomic analysis of Caenorhabditis elegans lipid droplets and identification of ACS-4 as a lipid droplet-associated protein. Biochimica et Biophysica Acta (BBA)—Molecular and Cell Biology of Lipids. 2015;1851(10):1337–45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Benador IY, Veliova M, Mahdaviani K, Petcherski A, Wikstrom JD, Assali EA, et al. Mitochondria Bound to Lipid Droplets Have Unique Bioenergetics, Composition, and Dynamics that Support Lipid Droplet Expansion. Cell metabolism. 2018;27(4):869–85.e6. 10.1016/j.cmet.2018.03.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Rambold Angelika S, Cohen S, Lippincott-Schwartz J. Fatty Acid Trafficking in Starved Cells: Regulation by Lipid Droplet Lipolysis, Autophagy, and Mitochondrial Fusion Dynamics. Developmental cell. 2015;32(6):678–92. 10.1016/j.devcel.2015.01.029 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Singh R, Kaushik S, Wang Y, Xiang Y, Novak I, Komatsu M, et al. Autophagy regulates lipid metabolism. Nature. 2009;458:1131 10.1038/nature07976 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Saito T, Kuma A, Sugiura Y, Ichimura Y, Obata M, Kitamura H, et al. Autophagy regulates lipid metabolism through selective turnover of NCoR1. Nature communications. 2019;10(1):1567 10.1038/s41467-019-08829-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Pellegrino MW, Nargund AM, Haynes CM. Signaling the mitochondrial unfolded protein response. Biochimica et Biophysica Acta (BBA)—Molecular Cell Research. 2013;1833(2):410–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Honjoh S, Yamamoto T, Uno M, Nishida E. Signalling through RHEB-1 mediates intermittent fasting-induced longevity in C. elegans. Nature. 2008;457:726 10.1038/nature07583 [DOI] [PubMed] [Google Scholar]
  • 91.Cooper JF, Machiela E, Dues DJ, Spielbauer KK, Senchuk MM, Van Raamsdonk JM. Activation of the mitochondrial unfolded protein response promotes longevity and dopamine neuron survival in Parkinson’s disease models. Scientific Reports. 2017;7(1):16441 10.1038/s41598-017-16637-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Kim KH, Lee M-S. Autophagy—a key player in cellular and body metabolism. Nature Reviews Endocrinology. 2014;10:322 10.1038/nrendo.2014.35 [DOI] [PubMed] [Google Scholar]
  • 93.Rabinowitz JD, White E. Autophagy and Metabolism. Science (New York, NY). 2010;330(6009):1344–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94.Lin Y-F, Haynes CM. Metabolism and the UPRmt. Molecular cell. 2016;61(5):677–82. 10.1016/j.molcel.2016.02.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Mouysset J, Kähler C, Hoppe T. A conserved role of Caenorhabditis elegans CDC-48 in ER-associated protein degradation. Journal of Structural Biology. 2006;156(1):41–9. 10.1016/j.jsb.2006.02.015 [DOI] [PubMed] [Google Scholar]
  • 96.Takahashi M, Iwasaki H, Inoue H, Takahashi K. Reverse Genetic Analysis of the Caenorhabditis elegans 26S Proteasome Subunits by RNA Interference. Biological Chemistry 2002. p. 1263 10.1515/BC.2002.140 [DOI] [PubMed] [Google Scholar]
  • 97.Baker BM, Nargund AM, Sun T, Haynes CM. Protective coupling of mitochondrial function and protein synthesis via the eIF2alpha kinase GCN-2. PLoS genetics. 2012;8(6):e1002760 10.1371/journal.pgen.1002760 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98.Brenner S. The Genetics of Caenorhabditis Elegans. Genetics. 1974;77(1):71–94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99.Simmer F, Tijsterman M, Parrish S, Koushika SP, Nonet ML, Fire A, et al. Loss of the Putative RNA-Directed RNA Polymerase RRF-3 Makes C. elegans Hypersensitive to RNAi. Current Biology. 2002;12(15):1317–9. 10.1016/s0960-9822(02)01041-2 [DOI] [PubMed] [Google Scholar]
  • 100.Springer W, Hoppe T, Schmidt E, Baumeister R. A Caenorhabditis elegans Parkin mutant with altered solubility couples α-synuclein aggregation to proteotoxic stress. Human Molecular Genetics. 2005;14(22):3407–23. 10.1093/hmg/ddi371 [DOI] [PubMed] [Google Scholar]
  • 101.Pujol N, Cypowyj S, Ziegler K, Millet A, Astrain A, Goncharov A, et al. Distinct Innate Immune Responses to Infection and Wounding in the C. elegans Epidermis. Current Biology. 2008;18(7):481–9. 10.1016/j.cub.2008.02.079 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102.Kang C, You Y-j, Avery L. Dual roles of autophagy in the survival of Caenorhabditis elegans during starvation. Genes & Development. 2007;21(17):2161–71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103.Urano F, Calfon M, Yoneda T, Yun C, Kiraly M, Clark SG, et al. A survival pathway for Caenorhabditis elegans with a blocked unfolded protein response. The Journal of cell biology. 2002;158(4):639–46. 10.1083/jcb.200203086 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 104.Mariol M-C, Walter L, Bellemin S, Gieseler K. A rapid protocol for integrating extrachromosomal arrays with high transmission rate into the C. elegans genome. Journal of visualized experiments: JoVE. 2013(82):e50773–e. 10.3791/50773 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 105.Frøkjær-Jensen C, Wayne Davis M, Hopkins CE, Newman BJ, Thummel JM, Olesen S-P, et al. Single-copy insertion of transgenes in Caenorhabditis elegans. Nature Genetics. 2008;40:1375 10.1038/ng.248 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 106.Frøkjær-Jensen C, Davis MW, Sarov M, Taylor J, Flibotte S, LaBella M, et al. Random and targeted transgene insertion in Caenorhabditis elegans using a modified Mos1 transposon. Nature Methods. 2014;11:529 10.1038/nmeth.2889 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 107.Gibson DG, Young L, Chuang R-Y, Venter JC, Hutchison Iii CA, Smith HO. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nature Methods. 2009;6:343 10.1038/nmeth.1318 [DOI] [PubMed] [Google Scholar]
  • 108.Frøkjær-Jensen C, Davis MW, Ailion M, Jorgensen EM. Improved Mos1-mediated transgenesis in C. elegans. Nature Methods. 2012;9:117 10.1038/nmeth.1865 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 109.Jagasia R, Grote P, Westermann B, Conradt B. DRP-1-mediated mitochondrial fragmentation during EGL-1-induced cell death in C. elegans. Nature. 2005;433(7027):754–60. 10.1038/nature03316 [DOI] [PubMed] [Google Scholar]
  • 110.Sternberg SR. Biomedical Image Processing. Computer. 1983;16(1):22–34. [Google Scholar]
  • 111.Sato Y, Nakajima S, Shiraga N, Atsumi H, Yoshida S, Koller T, et al. Three-dimensional multi-scale line filter for segmentation and visualization of curvilinear structures in medical images. Medical Image Analysis. 1998;2(2):143–68. 10.1016/s1361-8415(98)80009-1 [DOI] [PubMed] [Google Scholar]
  • 112.Xiao R, Chun L, Ronan Elizabeth A, Friedman David I, Liu J, Xu XZS. RNAi Interrogation of Dietary Modulation of Development, Metabolism, Behavior, and Aging in C. elegans. Cell reports. 2015;11(7):1123–33. 10.1016/j.celrep.2015.04.024 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 113.Löfgren L, Forsberg G-B, Ståhlman M. The BUME method: a new rapid and simple chloroform-free method for total lipid extraction of animal tissue. Scientific Reports. 2016;6(1):27688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 114.Witting M, Maier TV, Garvis S, Schmitt-Kopplin P. Optimizing a ultrahigh pressure liquid chromatography-time of flight-mass spectrometry approach using a novel sub-2μm core–shell particle for in depth lipidomic profiling of Caenorhabditis elegans. Journal of Chromatography A. 2014;1359:91–9. 10.1016/j.chroma.2014.07.021 [DOI] [PubMed] [Google Scholar]
  • 115.O’Donnell VB, Dennis EA, Wakelam MJO, Subramaniam S. LIPID MAPS: Serving the next generation of lipid researchers with tools, resources, data, and training. Science Signaling. 2019;12(563):eaaw2964 10.1126/scisignal.aaw2964 [DOI] [PubMed] [Google Scholar]
  • 116.Kind T, Liu K-H, Lee DY, DeFelice B, Meissen JK, Fiehn O. LipidBlast in silico tandem mass spectrometry database for lipid identification. Nature Methods. 2013;10(8):755–8. 10.1038/nmeth.2551 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 117.Mok DZL, Sternberg PW, Inoue T. Morphologically defined sub-stages of C. elegans vulval development in the fourth larval stage. BMC developmental biology. 2015;15:26–. 10.1186/s12861-015-0076-7 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Gregory P Copenhaver

Transfer Alert

This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.

22 Aug 2019

Dear Dr Conradt,

Thank you very much for submitting your Research Article entitled 'Autophagy compensates for defects in mitochondrial dynamics' to PLOS Genetics. Your manuscript was fully evaluated at the editorial level and by three independent peer reviewers. The reviewers appreciated the attention to an important problem, but raised some substantial concerns about the current manuscript. Based on the reviews, we will not be able to accept this version of the manuscript, but we would be willing to review again a much-revised version. We cannot, of course, promise publication at that time.

While two of the reviewers found the manuscript to be well written, one thought that the logical flow and conciseness could be improved.  In addition, please be careful to ensure that all experiments presented in the manuscript are properly controlled and that conclusions are justified by appropriate statistical analysis.  Also, at least one reviewer noted that not all of the underlying numerical data is provided (Table S1 for example) – this is a PLOS policy, so please make sure to correct that in the revised version you submit. Your revisions should address the specific points made by each reviewer. We will also require a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript.

If you decide to revise the manuscript for further consideration at PLOS Genetics, please aim to resubmit within the next 60 days, unless it will take extra time to address the concerns of the reviewers, in which case we would appreciate an expected resubmission date by email to plosgenetics@plos.org.

If present, accompanying reviewer attachments are included with this email; please notify the journal office if any appear to be missing. They will also be available for download from the link below. You can use this link to log into the system when you are ready to submit a revised version, having first consulted our Submission Checklist.

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see our guidelines.

Please be aware that our data availability policy requires that all numerical data underlying graphs or summary statistics are included with the submission, and you will need to provide this upon resubmission if not already present. In addition, we do not permit the inclusion of phrases such as "data not shown" or "unpublished results" in manuscripts. All points should be backed up by data provided with the submission.

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool.  PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

PLOS has incorporated Similarity Check, powered by iThenticate, into its journal-wide submission system in order to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted articles. You will be contacted if needed following the screening process.

To resubmit, use the link below and 'Revise Submission' in the 'Submissions Needing Revision' folder.

[LINK]

We are sorry that we cannot be more positive about your manuscript at this stage. Please do not hesitate to contact us if you have any concerns or questions.

Yours sincerely,

Gregory P. Copenhaver

Editor-in-Chief

PLOS Genetics

Gregory Barsh

Editor-in-Chief

PLOS Genetics

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: This manuscript describes a relatively unexplored relationship between autophagic flux and the regulation of the UPRmt caused by impaired mitochondrial dynamics. A genome-wide RNAi screening approach was used to identify genes that are required for the activation of the UPRmt when mitochondrial fusion is compromised. 299 genetic suppressors of the fzo-1(tm1133) mutant-mediated activation of the UPRmt were identified from this screen of which three were components of the ESCRT. Interestingly, knockdown of these components do not rescue the defects in mitochondrial morphology observed with fzo-1(tm1133) but instead increase mitochondrial membrane potential which is believed to be related to the suppression of the UPRmt observed in this mutant. Using multiple assays, it was shown that RNAi against the ESCRT genes increases autophagy flux in wild-type animals and even more so in the fzo-1(tm1133) mutant. The connection between autophagic flux and the suppression of fzo-1(tm1133) UPRmt activation was validated with knockdown of let-363/mTOR which stimulates autophagy. Remarkably, blocking mitophagy using a pdr-1 mutant did not prevent the suppression of the UPRmt by fzo-1(tm1133). The authors further expanded their findings by testing the remainder of suppressors that had been identified for changes in autophagic flux, of which RNAi of 126 genes increased autophagy (as well as 17 with known autophagy roles totaling 143 suppressors). Finally, while most of the 143 genes also suppressed drp-1(tm1108) induction of the UPRmt, 90 also suppressed the UPRmt activation unrelated to the regulation of mitochondrial dynamics (i.e. the spg-7(ad2249 mutant). Overall the manuscript is well written and explores an interesting correlation between the regulation of the UPRmt with impaired mitochondrial dynamics and autophagic flux, albeit with little mechanism.

1) One of the main interpretations of this manuscript is that increased autophagic flux suppresses the UPRmt resulting from impaired mitochondrial dynamics by restoring mitochondrial homeostasis. However, this conclusion is based primarily on the increase in mitochondrial membrane potential observed with TMRE staining. Are other parameters in mitochondrial function improved as well such as oxygen consumption and ATP production?

2) Related to 1): are there any physiological differences in fzo-1(tm1133) animals when autophagic flux is increased that might support the author’s claim of improved cellular homeostasis? For example thrashing rate, developmental rate, or possibly lifespan?

3) The authors also connect the increase in membrane potential with the regulation of ATFS-1 which is based on mitochondrial import efficiency. Is mitochondrial import improved in fzo-1(tm1133) animals with increased autophagic flux? It would be interesting to examine import efficiency using mitochondrial targeted GFP similar to what was described in Nargund et al. 2012.

4) The authors were not able to show that increased autophagy is necessary for the suppression of the UPRmt in fzo-1(tm1133) animals following ESCRT RNAi because of the embryonic lethality that is observed when the RNAi is performed in the fzo-1(tm1133; unc-51(e369) double mutant background. This is unfortunate since this experiment is rather important to test their central hypothesis. Would a milder form of unc-51 knockdown prevent this associated lethality? Possibly double RNAi against unc-51 and vps-4/20/27 in the fzo-1(tm1133) background? Or introducing a RNAi-hypersensitive mutant (e.g. rrf-3) into the fzo-1(tm1133); unc-51(e69) background which might allow for RNAi to occur in larvae?

5) on p.13, let-363 RNAi suppresses the UPRmt reporters in fzo-1(tm1133) animals to approximately the same level as their control ges-1::GFP. The authors then state however that let-363 RNAi increases TMRE by 19%, supporting their claim that autophagic flux suppresses this UPRmt activation by restoring mitochondrial membrane potential. However, the 19% increase does not appear to be significant based on their quantification in Figure 2F. Is this statement valid then? The same issue also applies to their finding that hars-1 RNAi suppresses ges-1::GFP expression and leads to a 12% increase in TMRE fluorescence which, according to their graph in 2F, is not significant.

Reviewer #2: My review is uploaded as an attachment

Reviewer #3: In the manuscript entitled " Autophagy compensates for defects in mitochondrial dynamics”, Haeussler and colleagues report an analysis of the mitochondrial dynamics using the nematode C. elegans. They first confirm that the depletion of FZO-1 and DRP-1, the respective homologs of mammalian MFN and DRP1, affects the mitochondrial network and show that both mutant induce mitochondrial UPR. The authors performed a genome wide RNAi screen to identify genes which depletion suppresses the UPRmit phenotype of the fzo-1 mutant. Among the candidates, they analyzed further the components of the ESCRT machinery. They show that in fzo-1 mutant there is an induction of autophagy flux and propose that it suppresses the UPRmit. A blockage of autophagy also induces UPRmit. By an RNAi approach, the authors claim that 143 genes are negative regulators of autophagy.

The results presented in the manuscript represent a substantial amount of work, in particular the genome-wide RNAi screen, but several major problems are weakening these results. The main problems concern the absence of clear biological questions driving the experiments, the miss of several controls and the fact that some conclusions are based on single observations and should be confirmed by another independent approach.

1) The result section starts by the description than fzo-1 and drp-1 mutants induce UPRmit.

The two first pages of the results are discussing which reporter of UPRmit is good between a multi copy zcIs13 versus single copy bcSi9, but finally the authors use both strains. This section is not very informative or useful for the rest of the manuscript.

One aspect that is not addressed in the paper is the possibility of tissue-specific effects. It is known that the mitochondrial network is not similar in all C. elegans tissues? Are all the fzo-1 mutant tissues behaving similarly? In figure 1, close up are necessary to see in what tissues hsp-6::GFP and hsp-60::GFP are increased. It is essential to describe what happens in muscle or in epidermis, because these tissues are used to test mitochondrial fragmentation in Fig 2C or TMRE in Fig 2D,E, respectively. Moreover, the quantification of autophagic puncta has been performed within a sub population of epidermal cells (the seam cells).

2) Using an RNAi approach the authors show that the depletion of several ESCRT components suppresses UPRmit in fzo-1 mutant.

In figure 1, some controls are missing. All RNAi should be also shown in the wild-type background and not only in fzo-1(tm1133). What is the efficiency of RNAi ? It has been shown that RNAi against ESCRT are not always recapitulating mutant phenotypes (ref. 36), so mutants could be used to confirm the RNAi phenotype. This is important for ESCRT components which depletion does not present any effect on fzo-1 phenotypes (vps-20 and vps-36).

3) From figure 2, the authors conclude that ESCRT depletion does not improve mitochondrial fragmentation but increases membrane potential. The mitochondrial fragmentation is shown in muscle and the mitochondrial dye TMRE is used in epidermis to analyze the mitochondrial potential membrane. For Fig 2C, pictures of mitoGFP in ESCRT(RNAi) alone should be shown.

TMRE data are not really convincing because alone it does not allow deciphering between a change in the membrane potential and a change in the mitochondrial mass. One possibility is to combine TMRE with another mitochondrial dye independent of MMP, or a GFP marker of the mitochondria. It is surprising that fzo-1 mutant have almost no staining with TMRE in Fi g2D. The measure of the oxygen consumption rate should be also perform to confirm these data.

4) The authors convincingly show that there is an increase of autophagic flux in fzo-1 animals. Fig 3C is too small and data are not quantified.

ESCRT(RNAi); fzo-1 animals present a further increase in autophagy. It supports previously published data showing that ESCRT depletion induces autophagic flux but does not prove that there is a causal link between FZO-1 and ESCRT. In Fig 3E, controls for ESCRT(RNAi) alone are not shown.

5) Using let-363(RNAi) (TOR homolog), the authors conclude that an autophagy induction suppresses the mitochondrial UPR in fzo-1 mutant. mTOR is involved in regulating autophagy but also in many others processes that can affect homeostasis and let-363 animals have many phenotypes. It could be useful to show that a blockage of autophagy flux (atg-5, atg-7 …) in let-363 mutant blocks the effect on UPRmit.

6) The paragraph “Depletion of ESCRT components in fzo-1(tm1133) animals with a block in autophagy results in embryonic lethality” is not informative because the authors could not test whether the increase of autophagic flux in ESCRT depleted fzo-1 animals is responsible of the improvement of mitochondrial UPR. Then, they tested RNAi against one pathway involved in mitophagy. However, the authors have not demonstrated that there is mitophagy occurring in fzo-1 mutants or ESCRT(RNAi); fzo-1. Moreover, there are others mitophagic pathways parallel to PDR-1 which have not been tested (Fundc1). The conclusion of this section is rather weak.

7) The authors show data indicating that blocking autophagy induces UPRmit but does not further increase UPRmit in fzo-1. It would be interesting to test whether it is due to an accumulation of damages that are not removed or an active induction.

Conversely depleting ATFS-1 does not modify autophagic response of fzo-1 animals. Unfortunately, the effect of overexpression could not been studied.

8) The last part of the manuscript presents a combination of data mining and RNAi to identify 143 candidates that the authors qualify of “negative regulators of autophagy”. This is affirmed on the observation that RNAi of these genes results in increase of GFP::LGG-1 dots in the seam cells and no accumulation of SQST-1. Six genes among the 143 candidates have been further tested for autophagy induction after RNAi depletion.

This approach shows that autophagy is potentially increased upon RNAi treatments, but it could be a very indirect consequence. Demonstrating that the overexpression of these proteins decrease the autophagic flux is necessary to conclude that these candidates are bona fide negative regulators.

9) In the discussion, an interesting hypothesis proposes that the modifications of mitochondrial networks (fzo-1 and drp-1) induce the UPRmit and then a metabolic change. Do the authors have any data about a potential metabolic shift?

Authors should discuss the potential mechanism(s) of action of ESCRTs on autophagy and mitochondrial dynamics. ESCRT defective mutant triggers an adaptative autophagic flux, but recent data have shown that ESCRT are involved in autophagosome closure (Takahashi Nature com 2018; Zhou JCB 2019).These references should be added and discussed.

Minor points

- For laudable pedagogic reason the authors propose a combination of C. elegans and human names for genes and proteins, but it does not respect the C. elegans nomenclature and in particular cases complicate the comprehension (Phsp-6 mtHSP70gfp).

- C. elegans Vps-27 official name is Hgrs.

- LGG-1 is the homolog of the GABARAP family rather than the LC3

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: Yes

Reviewer #2: No: Numerical data underlying Table S1 is not provided.

Reviewer #3: None

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Keith Nehrke

Reviewer #3: No

Attachment

Submitted filename: PLoS Genetic July 2019 review.docx

Decision Letter 1

Gregory P Copenhaver

28 Jan 2020

Dear Dr Conradt,

We are pleased to inform you that your manuscript entitled "Autophagy compensates for defects in mitochondrial dynamics" has been editorially accepted for publication in PLOS Genetics. Congratulations!

Reviewers #1 and #2 are now satisfied with the manuscript and were quite complementary of the effort to address their prior comments.  Reviewer #3 has some remaining concerns.  I believe these can be addressed, if necessary (see below), textually while preparing the final draft of your manuscript for the production team (the editorial team will not need to re-evaluate the manuscript).  Regarding the specific issues raised by Reviewer #3:

  1. Close-up of UPRmt reporters in the intestine – the other reviewers did not see this as necessary, so I won’t make acceptance contingent on it.  If you now have additional images of this type that you’d like to add, feel free to include them.

  2. Description of RNAi depletion – please address this in the text.

  3. Title – please consider whether the title needs to be modified.  Ultimately, I’ll leave this up to you, but in my experience, over-reaching is often more deleterious than circumspection. 

  4. Figure 7 & S8 – please add quantitative descriptions as appropriate. 

Before your submission can be formally accepted and sent to production you will need to complete our formatting changes, which you will receive in a follow up email. Please be aware that it may take several days for you to receive this email; during this time no action is required by you. Please note: the accept date on your published article will reflect the date of this provisional accept, but your manuscript will not be scheduled for publication until the required changes have been made.

Once your paper is formally accepted, an uncorrected proof of your manuscript will be published online ahead of the final version, unless you’ve already opted out via the online submission form. If, for any reason, you do not want an earlier version of your manuscript published online or are unsure if you have already indicated as such, please let the journal staff know immediately at plosgenetics@plos.org.

In the meantime, please log into Editorial Manager at https://www.editorialmanager.com/pgenetics/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production and billing process. Note that PLOS requires an ORCID iD for all corresponding authors. Therefore, please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field.  This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.

If you have a press-related query, or would like to know about one way to make your underlying data available (as you will be aware, this is required for publication), please see the end of this email. If your institution or institutions have a press office, please notify them about your upcoming article at this point, to enable them to help maximise its impact. Inform journal staff as soon as possible if you are preparing a press release for your article and need a publication date.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Genetics!

Yours sincerely,

Gregory P. Copenhaver

Editor-in-Chief

PLOS Genetics

Gregory Barsh

Editor-in-Chief

PLOS Genetics

www.plosgenetics.org

Twitter: @PLOSGenetics

----------------------------------------------------

Comments from the reviewers (if applicable):

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: I am satisfied with the revision experiments that were performed. There was a clear effort made for those experiments that were unsuccessful, which were not possible due to technical considerations.

Reviewer #2: In general, I feel that the rebuttal is responsive and addresses many of the reviewers' concerns. It is unfortunate that several attempts to provide additional data met with technical challenges, but the authors made a good faith effort, and the overall conclusions have been strengthened in the revised version. I also appreciated their ending with the lipid story, as it serves as an appropriate segue into future studies. This is a complicated story, but one well-worth spending time dissecting.

Reviewer #3: The revision of the manuscript by Haeussler and colleagues has improved several aspects and questions that I mentioned on the original version. A number of controls have been added and the authors have better explained some technical aspects that were unclear, e.g. the quantification of mitochondrial staining.

There are still some concerns about the replies to specific points and a comment about the new results:

- Point1. The justification for not showing close-up of UPRmt reporters in the intestine and the epidermis is not really convincing.

- Point 2 about RNAi efficiency has not be really addressed. It is important for genes whose depletion by RNAi does not result in the suppression of UPRmt. The negative result for ESCRT-II vps-22; vps-36 could be due to RNAi inefficiency and conclusion in line 220 is inappropriate.

- Point 5. There is a correlation between induction of autophagy and suppression of UPRmit, but unfortunately, the authors did not succeed to show that blocking autophagy inhibits the suppression of UPRmt observed in LET-363 or ESCRT mutants. In absence of an evidence, the tittle of the manuscript and the interpretation of the results should be more careful.

- The new data described in the lipidomic approach are interesting but what are the quantitative effects (Panel B in figure 7 and panels C and D in figure S8) ? An indication about fold change threshold for up and down regulated lipids is necessary.

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: None

Reviewer #2: Yes

Reviewer #3: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Keith Nehrke

Reviewer #3: No

----------------------------------------------------

Data Deposition

If you have submitted a Research Article or Front Matter that has associated data that are not suitable for deposition in a subject-specific public repository (such as GenBank or ArrayExpress), one way to make that data available is to deposit it in the Dryad Digital Repository. As you may recall, we ask all authors to agree to make data available; this is one way to achieve that. A full list of recommended repositories can be found on our website.

The following link will take you to the Dryad record for your article, so you won't have to re‐enter its bibliographic information, and can upload your files directly: 

http://datadryad.org/submit?journalID=pgenetics&manu=PGENETICS-D-19-01004R1

More information about depositing data in Dryad is available at http://www.datadryad.org/depositing. If you experience any difficulties in submitting your data, please contact help@datadryad.org for support.

Additionally, please be aware that our data availability policy requires that all numerical data underlying display items are included with the submission, and you will need to provide this before we can formally accept your manuscript, if not already present.

----------------------------------------------------

Press Queries

If you or your institution will be preparing press materials for this manuscript, or if you need to know your paper's publication date for media purposes, please inform the journal staff as soon as possible so that your submission can be scheduled accordingly. Your manuscript will remain under a strict press embargo until the publication date and time. This means an early version of your manuscript will not be published ahead of your final version. PLOS Genetics may also choose to issue a press release for your article. If there's anything the journal should know or you'd like more information, please get in touch via plosgenetics@plos.org.

Acceptance letter

Gregory P Copenhaver

11 Mar 2020

PGENETICS-D-19-01004R1

Autophagy compensates for defects in mitochondrial dynamics

Dear Dr Conradt,

We are pleased to inform you that your manuscript entitled "Autophagy compensates for defects in mitochondrial dynamics" has been formally accepted for publication in PLOS Genetics! Your manuscript is now with our production department and you will be notified of the publication date in due course.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript.

Soon after your final files are uploaded, unless you have opted out or your manuscript is a front-matter piece, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting PLOS Genetics and open-access publishing. We are looking forward to publishing your work!

With kind regards,

Kaitlin Butler

PLOS Genetics

On behalf of:

The PLOS Genetics Team

Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom

plosgenetics@plos.org | +44 (0) 1223-442823

plosgenetics.org | Twitter: @PLOSGenetics

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Comparison of expression levels and inter-individual variability of multi-copy Phsp-6 mtHSP70gfp (zcIs13) and single-copy integrated Phsp-6 mtHSP70gfp (bcSi9) transgenes.

    (A) Brightfield (upper panel) and fluorescence images (lower panel) of L4 larvae expressing Phsp-6gfp (zcIs13) in wild type (+/+), spg-7(ad2249), fzo-1(tm1133) or drp-1(tm1108). Scale bar: 200 μm. (B) Brightfield (upper panel) and fluorescence images (lower panel) of L4 larvae expressing Phsp-6gfp (bcSi9) in wild type (+/+), spg-7(ad2249), fzo-1(tm1133) or drp-1(tm1108). Scale bar: 200 μm. (C) Quantifications of fluorescence images of panel A (Phsp-6gfp (zcIs13)) are shown. Each dot represents quantification of 15–20 L4 larvae. Values indicate means ± SD of ≥5 independent measurements. (D) Quantifications of fluorescence images of panel B (Phsp-6gfp (bcSi9)) are shown. Each dot represents quantification of 15–20 L4 larvae. Values indicate means ± SD of ≥4 independent measurements. (E) Quantifications of western blot analysis of endogenous HSP-6 levels in wild-type (+/+), spg-7(ad2249), fzo-1(tm1133) or drp-1(tm1108) using anti-HSP-6 antibodies. For each genotype, 100 L4 larvae were harvested per experiment for western blot analysis. Values indicate means of relative HSP-6 expression (HSP-6/TUB) ± SD, n = 2. (F) Inter-individual variability in gene expression of target genes in bcSi9 and zcIs13 in both wild type (+/+) and fzo-1(tm1133). To estimate inter-individual variability in gene expression, the coefficient of variation was calculated from individual mRNA levels obtained from normalized Ct values using the delta Ct method. Inter-individual variability values were normalized such that variability values for nlp-29 in wild type = 1 (bcSi9 or zcIs13). Number of individual worms: n = 35 (bcSi9), n = 32 (bcSi9; fzo-1(tm1133)), n = 31 (zcIs13), n = 31 (zcIs13; fzo-1(tm1133)).

    (TIF)

    S2 Fig. RNAi against vps-4VPS4 and vps-20CHMP6 suppresses expression of bcSi9 and induces autophagy in wild type (+/+).

    (A) L4 larvae were subjected to control(RNAi), atfs-1(RNAi), vps-4(RNAi) or vps-20(RNAi) and the F1 generation was imaged. Each dot represents the quantification of fluorescence intensity of 15–20 L4 larvae. Values indicate means ± SD of 5 independent experiments in duplicates. *P<0.05, ***P<0.001 using one-way ANOVA with Dunnett’s multiple comparison test to control(RNAi). (B) Plgg-1gfp::lgg-1 expression of L4 larvae in hypodermal seam cells and intestinal cells upon control(RNAi), vps-4(RNAi) or vps-20(RNAi). Representative images of >30 animals from two independent biological replicates are shown. Scale bar hypodermal seam cells: 5 μm. Scale bar intestinal cells: 20 μm.

    (TIF)

    S3 Fig. Knock-down of ESCRT components in body wall muscle cells of wild type and intestinal cells in fzo-1(tm1133) does not change mitochondrial morphology.

    (A) Fluorescence images of L4 larvae expressing Pmyo-3gfpmt in wild type (+/+). L4 larvae were subjected to control(RNAi), atfs-1(RNAi), vps-4(RNAi), vps-20(RNAi) or let-363(RNAi) and the F1 generation was imaged. Scale bar: 10 μm. (B) Fluorescence images of L4 larvae expressing Plet-858gfpmt in wild type (+/+) or fzo-1(tm1133). L4 larvae were subjected to control(RNAi), atfs-1(RNAi), vps-4(RNAi), vps-20(RNAi) or let-363(RNAi) and the F1 generation was imaged. Scale bar: 10 μm.

    (TIF)

    S4 Fig. Image segmentation and intensity measurement workflow.

    A raw 16-bit image (1) is converted to 8-bit, followed by a background subtraction using the rolling ball algorithm (2). This is followed by the successive application of a minimum (3) and average filter (4). The ImageJ Tubeness plugin generates an image with object curvature scores (5), after which the IsoData autothresholding is applied to generate the binary mask (6). Noise is removed by filtering out particles below a certain size (7) and the final mask is used to define the area in which intensity measurements are obtained (8). Scale bar: 5 μm.

    (TIF)

    S5 Fig. Thrashing assay in wild-type and fzo-1(tm1133) animals upon induction of autophagy.

    Thrashing rate was analyzed by counting body bends of animals swimming for 1 minute in M9 buffer in 3 independent experiments. Each dot represents one L4 larvae. (A) Thrashing rates of wild-type (+/+) or fzo-1(tm1133) L4 larvae. ****P<0.0001 using unpaired two-tailed t-test. n = 30. (B) Thrashing rates in wild-type animals upon induction of autophagy. L4 larvae were subjected to control(RNAi), vps-4(RNAi), vps-20(RNAi), let-363(RNAi) or hars-1(RNAi) and the F1 generation was analyzed. ns: not significant, ****P<0.0001 using Kruskal-Wallis test with Dunn’s multiple comparison test to control(RNAi). n = 30. (C) Thrashing rates in fzo-1(tm1133) animals upon induction of autophagy. L4 larvae were subjected to control(RNAi), vps-4(RNAi), vps-20(RNAi), let-363(RNAi) or hars-1(RNAi) and the F1 generation was analyzed. ns: not significant, ***P<0.001 using Kruskal-Wallis test with Dunn’s multiple comparison test to control(RNAi). n = 30.

    (TIF)

    S6 Fig. RNAi against vps-4VPS4 and vps-20CHMP6 does not suppress fzo-1(tm1133)-induced UPRmt when diluted with control(RNAi) or carried out in one generation from L2 to L4 larvae.

    (A) Quantifications of fluorescence images of L4 larvae expressing Phsp-6gfp (bcSi9) in fzo-1(tm1133). Each ESCRT(RNAi) was diluted 1:1 with control(RNAi). After subtracting the mean fluorescence intensity of wild type (+/+) on control(RNAi), the values were normalized to fzo-1(tm1133) on control(RNAi). Each dot represents the quantification of fluorescence intensity of 15–20 L4 larvae. Values indicate means ± SD of 3 independent experiments in duplicates. ns: not significant, using one-way ANOVA with Dunnett’s multiple comparison test to control(RNAi). (B) Quantifications of fluorescence images of L4 larvae expressing Phsp-6gfp (bcSi9) in fzo-1(tm1133). L2 larvae were subjected to control(RNAi), atfs-1(RNAi), vps-4(RNAi) or vps-20(RNAi) and the same animals were imaged in L4 stage. After subtracting the mean fluorescence intensity of wild type (+/+) on control(RNAi), the values were normalized to fzo-1(tm1133) on control(RNAi). Each dot represents the quantification of fluorescence intensity of 15–20 L4 larvae. Values indicate means ± SD of 4 independent experiments in duplicates. ns: not significant, **P<0.01 using Kruskal-Wallis test with Dunn’s multiple comparison test to control(RNAi). (C) Plgg-1gfp::lgg-1 expression of fzo-1(tm1133) L4 larvae in hypodermal seam cells and intestinal cells. L2 larvae were subjected to control(RNAi), vps-4(RNAi) or vps-20(RNAi) and the same animals were imaged in L4 stage. Representative images of >60 animals from two independent biological replicates are shown. Scale bar hypodermal seam cells: 5 μm. Scale bar intestinal cells: 20 μm. (D) Quantifications of fluorescence images of L4 larvae expressing Phsp-6gfp (bcSi9) in fzo-1(tm1133) rrf-3(pk1426). L2 larvae were subjected to control(RNAi), atfs-1(RNAi), vps-4(RNAi) or vps-20(RNAi) and the same animals were imaged in L4 stage. After subtracting the mean fluorescence intensity of wild type (+/+) on control(RNAi), the values were normalized to fzo-1(tm1133) on control(RNAi). Each dot represents the quantification of fluorescence intensity of 15–20 L4 larvae. Values indicate means ± SD of 4 independent experiments in duplicates. ns: not significant, ****P<0.0001 using one-way ANOVA with Dunnett’s multiple comparison test to control(RNAi).

    (TIF)

    S7 Fig. Autophagy is induced in spg-7(ad2249) animals.

    (A) Plgg-1gfp::lgg-1 expression in hypodermal seam cells of wild type (+/+) or spg-7(ad2249) L4 larvae. Scale bar: 5 μm. (B) Quantification of GFP::LGG-1 foci in hypodermal seam cells from panel A. Each dot represents the average amount of GFP::LGG-1 foci counted from 2–5 seam cells in one animal. n≥18 for each genotype; values indicate means ± SD; **P<0.01 using unpaired two-tailed t-test with Welch’s correction. (C) Nomarski and fluorescent images of the Psqst-1sqst-1::gfp translational reporter in embryos of wild type (+/+) and spg-7(ad2249) animals. As a positive control for a block in autophagy, unc-51(e369) was used. Representative images of >60 embryos are shown. Scale bar: 10 μm.

    (TIF)

    S8 Fig. Defects in mitochondrial homeostasis lead to major changes in lipid metabolism.

    (A) Venn diagrams showing the overlap of lipids up- or downregulated in fzo-1(tm1133), drp-1(tm1108) and spg-7(ad2249) in comparison to wild type (+/+). (B) Total amount of TGs in wild type (+/+), fzo-1(tm1133), drp-1(tm1108) and spg-7(ad2249) backgrounds. Means ± SD are shown; ns: not significant, *P<0.05, ****P<0.0001 using Welch test. (C) Scatterplot indicating the distribution and changes in the levels of TG species in the different mutants in comparison to wild type (+/+). (D)) Scatterplot indicating the overlap of the changes in the levels of TG species of fzo-1(tm1133) and drp-1(tm1108) mutants in comparison to wild type (+/+). (C) and (D) The x-axis labels the number of carbons (# of C) and the y-axis the number of double bonds (DB) in the acyl sidechains. The size of a dot indicates the number of detected isomers for a specific sum composition. Grey dots represent all detected TGs species and blue and red dots indicate down- (blue) or upregulation (red).

    (TIF)

    S9 Fig. Induction of autophagy upon cogc-2(RNAi) changes the levels of specific TGs in fzo-1(tm1133) mutants.

    (A) Scatterplot indicating the distribution and changes in the level of TG species in fzo-1(tm1133) mutants in comparison to wild type (+/+). The x-axis labels the number of carbons (# of C) and the y-axis the number of double bonds (DB) in the acyl sidechains. The size of a dot indicates the number of detected isomers for a specific sum composition. Grey dots represent all detected TGs species and blue and red dots indicate down- (blue) or upregulation (red). (B) Venn diagram indicating the overlap of TG species downregulated (left panel) or upregulated (right panel) in fzo-1(tm1133) and downregulated upon vps-4(RNAi) or cogc-2(RNAi).

    (TIF)

    S1 Table. List of genes that suppress fzo-1(lf)-induced UPRmt and induce autophagy in wild-type animals upon knock-down.

    Candidate genes were identified in the primary RNAi-screen using fzo-1(tm1133), subsequently knocked-down and tested for induction of autophagy and re-screened for UPRmt suppression in two different mutant backgrounds: drp-1(tm1108) and spg-7(ad2249).

    (XLSX)

    S2 Table. Numerical data of lipidomic experiments.

    Significantly up- or downregulated lipids in fzo-1(tm1133), drp-1(tm1108) or spg-7(ad2249) mutants (Sheet 1), significantly up- or downregulated TGs in fzo-1(tm1133), drp-1(tm1108) or spg-7(ad2249) mutants (Sheet 2) and significantly up- or downregulated TGs in fzo-1(tm1133) upon induction of autophagy by vps-4(RNAi) or cogc-2(RNAi) (Sheet 3). MS1 annotations, P-values and fold change are indicated.

    (XLSX)

    S3 Table. List of qRT-PCR primers.

    Primers used for qRT-PCR including PCR efficiency and coefficient of determination (R2).

    (XLSX)

    Attachment

    Submitted filename: PLoS Genetic July 2019 review.docx

    Attachment

    Submitted filename: Rebuttal letter_22December2019.pdf

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS Genetics are provided here courtesy of PLOS

    RESOURCES